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CHAPTER I
INTRODUCTION
The term “cancer” refers to a group o f diseases in which cells grow and
spread unrestrained throughout the body. It is difficult to imagine anyone who has
not heard about this disease. Cancer, as an illness o f man, has been described in the
history o f medicine since the earliest medical records were kept. For several
thousand years, cancer was visible only in its outward manifestations (Health
Canada, 1999).
Cancer arises from a loss o f normal growth control. In normal tissues, the
rates o f new cell growth and old cell death are kept in balance. In cancer, this
balance is disrupted. This disruption can result from uncontrolled cell growth or loss
of a cell’s ability to undergo “apoptosis.” Apoptosis, or “cell suicide,” is the
mechanism by which old or damaged cells normally self-destruct (National Cancer
Institute, 2000).
Cancer is often perceived as a disease that strikes for no apparent reason.
This is because scientists don’t know all the reasons. However, many o f the causes
of cancer have already been identified. Besides heredity, scientific studies point to
the existence o f three main categories o f factors that contribute to the development
o f cancer: chemicals (e.g., from smoking or diet), radiation, and viruses or bacteria
(Newton, Beral, Weiss, & Tooze, 1999).
1
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Among these contributors, chemicals play a significant role in causing
cancer. Since exposure to chemical carcinogens (cancer-causing agents) is
responsible for triggering most human cancers, people can reduce their risk of
cancer by taking steps to avoid or minimize the exposure to such agents (Harras,
Edwards, Bolt, & Gloeckler Ries, 1997). Hence, a very important step in cancer
prevention is to identify the behaviors or exposures to particular kinds o f chemical
carcinogens that represent the greatest cancer hazard.
Chemical carcinogenesis was first recognized in the human approximately
two and half centuries ago by findings o f Hill in 1761 who noted an increased
incidence o f nasal polyps and cancer after the prolonged and excessive use of
tobacco snuff (Augusto, Cavalieri, Rogan, RamaKrishna, & Kolar, 1978). In 1775
Percival Pott noted the scrotal skin cancer o f chimney sweeps and correlated it to
the exposure o f these patients for many years to large amounts o f coal soot and tar
(Josephy, 1997). Even in that early era, the effects o f certain chemical exposures as
cancer causing agents were recognized.
It is considered that for chemical carcinogens to be effective, they must
interact with cellular macromolecular constituents, including proteins, lipids, and
more importantly, with nucleic acids (Waalkes & Ward, 1994). One basic
mechanism in chemical carcinogenesis is the formation o f covalent bonds between
chemical carcinogens and DNA, RNA, and protein to form adducts. These adducts
are thought to interfere with replication leading to mutation or deletion o f a DNA
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sequence. Mutation is considered the critical step in the process o f a tumor’s
formation (Miller, 1970).
During the past 60 years or so, following the identification of the first pure
chemical carcinogen (Kennaway & Hieger, 1930) no common factors or pathways
for the mechanism o f action o f chemical carcinogens from different chemical
classes have become evident. For this very reason, each class o f carcinogen is often
discussed separately. Today, the potential for D N A adduct formation is recognized
as a common property o f most potent carcinogens and the formation o f such adducts
is the basis o f several current strategies in molecular epidemiology and bio
monitoring (Dipple, 1995).
Despite the common aspect o f mechanisms for many chemical carcinogens,
the complexities o f metabolic activation and o f the chemistry and stereochemistry o f
adduct formation have tended to keep some degree o f compartmentalization in
research and in literature reviews o f DNA adduct formation by different classes o f
chemical compounds (Hemminki, 1994). Typically, a single toxic chemical class,
such as the polycyclic aromatic hydrocarbons (PAHs), induces many types o f DNA
damage. Particular adduct isomers may be dominant, however, many minor adducts
are also formed. For example, even simple alkylating agents react with guanine and
other bases at several sites (Augusto, Cavalieri, Rogan, RamaKrishna, & Kolar,
1990; Josephy, 1997; Netto et al., 1992). The formation o f methyl guanine adducts
is shown in Figure 1.
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Figure 1. Multiple Sites of Guanine Alkylation.

In many cases, the pattern o f DNA damage induced by an agent can serve as
a distinctive “fingerprint”. In general, if such a pattern is distinctive, then it may be
possible to work back from an observed spectrum of DNA adducts to deduce the
nature of the chemical agent responsible and to prevent or repair the damage to
DNA(Josephy, 1997).
Chemical carcinogens can be classified into three major categories. They are
direct acting (no metabolic activation needed), indirect acting (metabolic activation
needed), and nongenotoxic or epigenetic carcinogens (Waalkes & Ward, 1994).
Most chemical carcinogens are considered to be indirect acting. They require
metabolic activation to produce electrophilic intermediates in order for the tumor
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formation process to take place (Josephy, 1997). For example, the hypothesized
mechanism for metabolic activation o f polycyclic aromatic hydrocarbons (PAH), is
that activation occurs by two main routes: one-electron oxidation to yield reactive
intermediate radical cations (Cavalierri & Rogan, 1984, 1985; Cavalieri & Roth,
1976; Hanson, Rogan, & Cavalieri, 1998; Miller & Miller, 1981; Rogan etal., 1988;
Waalkes & Ward 1994) and monooxygenation to produce bay-region diol epoxides
(Cheh et al., 1993; Conney, 1982; Sims & Grover, 1981). These activated
intermediates then react with nucleotides or bases to form covalently bonded
compounds and cause a “molecular lesion.” In many cases, stable DNA adducts can
be found as evidence o f these reactions (Blobstein, Weinstein, Grunberger,
Weisgras, & Harvey, 1975; Cavalieri & Auerbach, 1974; Cavalieri et al., 1991;
Chakravarti, Pelling, Cavalieri, & Rogan, 1995; Chen et al., 1997; Cheng, Hilton,
Roman, & Dipple, 1989; Cremonesi, Hietbrink, Rogan, & Cavalieri, 1992;
Devanesan, Cremonesi, Nunnally, Rogan, & Cavalieri, 1990; Devanesan et al.,
1993; Dipple, Moschel, & Pigott, 1985; Fernando, Huang, Milliman, Shu, &
LeBreton, 1996; Herreno-Saenz, Evans, Abian, & Fu, 1993; Higginbotham,
RamaKrishna, Johansson, Rogan, & Cavalieri, 1993; Mulder, RamaKrishna,
Cremonesi, Rogan, & Cavalieri, 1993; Mulder et al., 1996; Pachuta et al., 1988;
RamaKrishna, Gao, Padmavathi, Cavalieri, & Rogan, 1992; RamaKrishna et al.
1993; Wilk & Girke, 1972).
The adducts formed by the above mechanisms can be either stable,
remaining in DNA unless repaired by natural repair enzymes, or depurinated and
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released from D N A by cleavage o f the glycosidic bond between the purine base and
deoxyribose (Josephy, 1997; Todorovic et al., 1997). Loss o f adducts by
depurination results in apurinic sites in the DNA, which, if not repaired, can also be
mutagentic. Therefore, the importance o f determination o f structure o f the DNA
adducts formed in target tissues is a critical variable requiring extensive research.
Researchers believe that study o f D N A adducts will help to yield an
understanding o f the mechanisms o f metabolic activation and, eventually, the
mechanisms o f tumor initiation (Cavalieri, Rogan, Devanesan, Jankowiak, & Small,
1997). The use o f DNA adducts as bio-markers for risk assessment and
environmental monitoring have caught researcher’s interest (Huang et al., 1998).
The DNA adduct represents direct evidence o f primary damage to DNA by a
chemical. Therefore, measuring DNA adducts may prove to be more precise and
reliable than measuring the external exposure (Groopman & Kensler, 1993; McCull,
Rindgen, Blair, & Penning, 1999).
DN A adducts are typically large molecules, and therefore structure
determination represents a very challenging problem in organic analysis. Deconvolution o f the chemical structures o f D N A adducts is usually based on
spectroscopic identification by nuclear magnetic resonance (NMR). However, NMR
analysis is possible only with purification o f many micrograms o f pure adducts and
in many cases, such quantities are hard to obtain. This is typically the case in living
organisms.
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The most productive approach has been to prepare authentic DNA adduct
standards by the reaction o f synthetic reactive intermediates with target nucleotides
or bases in vitro. Structural analysis is performed on the synthetic standards, and
DNA adducts formed in cell culture or in vivo are identified by Gas
Chromatography (GC) or High Performance Liquid Chromatography (HPLC) cochromatography (Josephy, 1997).
The detection and quantitation o f DNA adducts by the direct methods
described above is possible only when adducts are present in sufficiently large
amounts (pmole/mole DNA). For samples with lower levels of DNA adducts, the
radiolabled xenobiotic method ( 14C or 3H) and 32P postlabeling method (twodimensional thin-layer chromatography) are often used (Josephy, 1997). However,
each method has its own limitation. The GC and HPLC methods often lack
confirmation information. The radiolabeling method is expensive and is limited by
the relatively low specific activities o f 14C and 3H. The 32P postlabeling method
also lacks confirmation information and accurate quantitative work is difficult by
TLC.
Our research is focused upon the analysis o f the benzo[a]pyrene-DNA/
Guanine adducts at trace levels by modern instrumentation. The ultimate goal o f this
study is to provide a better method o f detecting the “bio-markers” for cancer
formation. In this work we have found upon detecting DNA adducts formed via the
free-radical activation pathway. This will enable future researchers to gain a better
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understanding o f cancer formation, which will in turn lead to better treatments o f the
disease.
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CHAPTER H
HISTORY AND LITERATURE REVIEW
Properties and History o f Benzo[a]pyrene
Benzo[a]pyrene is a five-ring polycyclic aromatic hydrocarbon (PAH), also
known as 3,4-benzyrene which was first isolated from coal tar. Later, it was found
to be a component o f cigarette and marijuana smoke (Lee, Novotny, & Bartle,
1976). Benzo[a]pyrene belongs to the PAH family, and comprises less than five
percent o f the total amount o f PAHs present in the atmosphere. Benzo[a]pyrene has
a molecular formula o f C20 H 12. It is a yellowish crystal with a molecular weight of
252.3. The boiling point o f benzo[a]pyrene is greater than 360°C at 760 mm Hg and
the melting point is approximately 179°C. The vapor pressure o f benzo[a]pyrene at
25°C is 8.4 x 10’7 Pa, enthalpy o f sublimation at 25°C is 118.3 ± 2.2 KJ / mol,
entropy o f sublimation at 25°C is 183.6 J / mol EK, enthalpy o f fusion is 16.6 ± 0.3
KJ / mol, IogP (octanol/water) is 6.04, and the Henry Constant is 2.7 x 10

-7

3

Atm-m

/ mol (Bjorseth, 1983; Ebert, 1986; Futoma, Smith, Smith, & Tanaka,1981). It is
soluble in benzene, xylene, and toluene. It is sparingly soluble in ethanol, methanol,
and insoluble in water. The structure and numbering o f benzo[a]pyrene are
displayed in Figure 2.

9
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Figure 2. Structure o f Benzo[a]pyrene.

Benzo[a]pyrene, after metabolic activation, is known as one o f the most
potent PAHs to cause carcinogenic effects (Fourth Annual Report on Carcinogens,
1985). It was first determined to be a carcinogen in the early 1950s by Elizabeth
Miller who found that a metabolite o f benzo[a]pyrene reacts with proteins in mouse
skin ( Miller, 1951). The principal sources o f benzo[a]pyrene and other PAHs in the
atmosphere are combustion o f fossil fuels in heat and power generation, refuse
burning, vehicle emission and coke ovens, together contributing over 50% o f the
total nationwide emissions (Bjorseth & Ramdahl, 1985). Emissions from these
sources are major contributors to urban environmental contamination, particularly in
areas adjacent to highways, industries, and airports. Although there are other natural
sources o f PAHs (e.g., volcanic activity and forest fires), the anthropogenic sources
are still considered to be the most significant sources o f benzo[a]pyrene and other
PAHs in air pollution. According to recent estimates, the annual emission o f
benzo[a]pyrene into the atmosphere o f the United States is over 1300 tons (Harvey,
1991).

10
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The United States Environmental Protection Agency (U.S. EPA) classified
benzo[a]pyrene as a “possible human carcinogen” (Group B2) and the International
Agency for Research on Cancer (IARC) considers benzo[a]pyrene a known animal
carcinogen and a probable human carcinogen (Group 2A). The OEHHA (The Office
o f Environmental Health Hazard-Assessment) staff agrees with the IARC
classification o f benzo[a]pyrene (IARC Group 2A) as a probable human carcinogen
based on sufficient evidence for carcinogenicity in animals and limited evidence in
humans. Benzo[a]pyrene has the ability through its metabolites to arylate DNA,
cause gene mutations in both prokaryotic and eukaryotic cells, induce sister
chromatic exchanges in mammalian cells, and produce unscheduled DN A synthesis
in mammalian cells (Environmental Protection Agency, 1998).
Several types o f malignant tumors have been induced in rodents by
benzo[a]pyrene. Epidemiological evidence for human cancer from exposure to
benzo[a]pyrene is found in studies o f roofers, tar distillers, patent-fiiel workers, and
creosote-exposed brickmakers. Certain complex mixtures such as soots, tars and oils
are in the IARC Group 1 (sufficient evidence for carcinogenicity in humans) based
on epidemiological studies. The federal government has developed standards and
guidelines to protect individuals from the potential health effects o f PAHs, including
benzo[a]pyrene, in drinking water. The U.S. Environmental Protection Agency
(EPA) has provided estimates of levels o f total cancer-causing PAHs in lakes and
streams associated with various risks o f developing cancer in people. The EPA has
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also determined that any release o f PAHs o f more than 1 pound should be reported
to the National Response Center (Environmental Protection Agency, 1998).
Pure benzo[a]pyrene is produced in the United States only as a laboratory
chemical. However, benzo[a]pyrene is a PAH, and PAHs are found in coal tar and
in the creosote oils and pitches formed from the production o f coal tar. The
government’s goal has been to protect workers involved with the production o f coal
tar products. These regulations are for exposure to benzo[a]pyrene in workplace air.
Although government standards are not for benzo[a]pyrene alone, they are useful in
controlling exposure to total PAHs.
The National Institute for Occupational Safety and Health (NIOSH) has
determined that workplace exposure to coal products can increase the risk o f lung
and skin cancer in workers. Based on that, NIOSH has suggests that the workplace
exposure limit for coal tar products is 0.1 milligram o f PAHs per cubic meter o f air
(0.1 mg/m ) for a 10-hour workday and 40-hour workweek. NIOSH has not
suggested a specific workplace limit for benzo[a]pyrene. However, the
Occupational Safety and Health Administration (OSHA) has set a legal limit o f 0.2
3

milligrams o f all PAHs per cubic meter o f air (0.2 mg/m ) (California Air Resources
Board and Office o f Environmental Health Hazard, 1994).
Benzo[a]pyrene/PAHs are widely distributed throughout the waters o f the
earth, entering the food chain by being taken up by fish and plankton (Harvey,
1991). Since some PAHs including benzo[a]pyrene are only slowly degraded, they
represent a potential health hazard to humans through drinking water and other
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sources. For example, the average level o f benzo[a]pyrene in drinking water is
found to be around O.Olug/L which is o f a similar level to that from breathing
reasonably clean air (Harvey, 1991).
The most common way benzo[a]pyrene enters the body is through the lungs
when a person breathes in air or smoke containing it. It also enters the body through
the digestive system when substances containing it are swallowed. Although
benzo[a]pyrene does not normally enter the body through the skin, small amounts
could enter if contact occurs with soil that contains high levels o f benzo[a]pyrene
(for example, near a hazardous waste site) or if contact is made with heavy oils
containing it (Agency for Toxic Substances and Disease Registry, 1990).
Benzo[a]pyrene is potent, because it has two main features: (1) a relatively
low ionization potential o f 7.23 eV (IP), which allows metabolic removal o f one
electron thus forming a cation (if IP< 7.35eV) (Cavalieri & Rogan, 1985;
Hemminki, 1994); and (2) appreciable charge localization in the radical cation,
which allows this intermediate to be especially and efficiently reactive with
nucleophiles (Dipple, 1995; Hemminki, 1994; Josephy, 1997). This is demonstrated
by adduct formation o f benzo[a]pyrene with DNA and has been widely studied and
published by various researchers (Cavalieri et al., 1990; Cavalieri et al., 1997;
Todorovic et al., 1997).
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Benzo[a]pyrene-DNA Adducts
Several benzo[a]pyrene-DNA adducts have been synthesized by either in
vitro or in vivo methods and identified by modern instrumentation. Those adducts
are used as standards for further studies o f benzo[a]pyrene carcinogenesis effects
(Roganetal., 1988).
A large body o f research exists on benzo[a]pyrene and PAHs. Among those
studies, guanine nucleosides were chosen most often because this base is most
frequently modified by chemical carcinogens in biological systems. It has been
reported that benzo[a]pyrene forms two major depurination adducts with guanine
(nucleoside) when reacted with DNA in vitro and in vivo. Several groups of
researchers have attempted similar studies. PAHs and other aromatic compounds
form covalent bonds with DNA nucleosides that provide valuable information on
the binding mechanism (Casale et al., 1997; Cavalieri, Devanesan, Mulder,
RamaKrishna, & Rogan, 1994; Cavalieri et al., 1990; Chen et al., 1996; Devanesan,
Todorovic, Rogan, & Cavalieri, 1994; Devanesan et al., 1996; Hoffman, Lesko, &
Ts’o, 1970; Humphreys, Kadlubar, & Guengerich, 1992; Jeffery, Blobstein,
Weinstein, & Harvey, 1976; Li, RamaKrishna, Padmavathi, Rogan, & Cavalieri,
1994; Li et al., 1995; McCull et al., 1999; Miller, 1951; RamaKrishna et al., 1992;
RamaKrishna et al., 1993; Rogan, Higginbotham, Devanesan, & Cavalieri, 1994;
Rogan et al., 1990; Ross et al., 1991; Sage & Haseltine, 1984; Slaga et al., 1977;
Stack, Cremonesi, Hanson, Cavalieri, & Rogan, 1995; Todorovic, Devanesan,
Rogan, & Cavalieri, 1993).
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According to these studies, it is believed that benzo[a]pyrene is activated by
two main routes: one-electron oxidation to yield reactive intermediate radical
cations (Cavalieri & Rogan, 1984, 1985; Cavalieri & Roth, 1976; Hanson et al,
1998; Miller & Miller, 1981; Rogan et al., 1988; Waalkes & Ward 1994) and
monooxygenation to produce bay-region diol epoxides (Cheh et al., 1993; Conney,
1982; Sims & Grover, 1981). These activated intermediates then react with
nucleotides or bases to form covalently bonded compounds and cause a “molecular
lesion.”
For the monooxygenation route, the major identified benzo[a]pyrene diol
epoxide adduct arises from formation of a covalent bond between C-10 of
benzo[a]pyrene diol epoxide and two amino o f guanine moieties on DNA (Rogan et
al., 1990; Weinstein et al., 1976). Figure 3 displays the scheme o f formation of
benzo[a]pyrene diol epoxide and its adducts by “monooxygenation” of
benzo[a]pyrene and reacted with DNA.
For the one-electron oxidation route, the benzo[a]pyrene was first activated
by one-electron oxidation to its radical cation. It then binds the C-6 of
benzo[a]pyrene to either the C-8 orN-7 o f guanine on DNA and forms adducts
(Rogan et al., 1990). They are 8-(benzo[a]pyrene-6-yl)guanine and 7(benzo[a]pyrene-6-yI)guanine (Rogan et al., 1988) (hereafter referred to as BaPC8Gua and BaP-N7Gua). Figure 4 displays the scheme of formation o f BaP-C8Gua
and BaP-N7Gua adducts by one electron oxidation o f benzo[a]pyrene reacted with
DNA.
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OH
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BPDE-N2Gua

nh2

BPDE-N7Gua

Figure 3. Formation o f BaP-DNA Adducts by Monooxygenation.

In some o f the benzo[a]pyrene/DNA research that has been done, BaPC 8 Gua and BaP-N7Gua were made and used as external standards in HPLC/UV
detection assays (typical detection limit was at pg/mL) for quantitative work (Rogan
et al., 1988). However, the analytical work that has been done on bio-samples was
lacking confirmation information due to the complexity o f sample matrix, especially
when tissue samples were used for analysis.
Research Goal and Instrumentation
Our research goal is to utilize high performance liquid chromatography/
tandem mass spectrometry to solve the analytical problems associated with
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one-electron
oxidation

H-N
H-N

NH

NH2
BaP-C8Gua

BaP-N7Gua

Figure 4. Formation o f BaP-DNA Adducts by One Electron Oxidation.

benzo[a]pyrene-DNA adduct isomer detection and provide accurate data for the
quantitative, qualitative work, and kinetic studies o f benzo[a]pyrene/DNA(BaPC 8 Gua and BaP-N7Gua) adduct formation in in vitro and in vivo samples .
Mass spectrometry has very unique selectivity. When coupled with GC or
HPLC it becomes a very powerful tool in analytical chemistry. It has been widely
used in industry and academia for years for different research. In mass spectrometry,
molecules are converted to ions and the ions are separated according to their massto-charge ratio (m/e). The prototype mass spectrometer was first made by J. J.
Thompson and the first mass spectrometer was developed by the British physicist
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Francis William Aston in 1919. Since then, it has been quickly adopted by
analytical chemists as one o f the most important research tools.
Despite the differences in mass spectrometry ion detection techniques, all
mass spectrometers have four features in common: ( 1 ) a device for sample
introduction, (2) a device for ionizing the sample, (3) an analyzer/mass filter that
directs the ions into the measuring device, and (4) a system for measuring the
constituent ions and recording the mass spectrum.
Typically, GC, HPLC, CE, ICP, and solid probe are commonly used inlet
devices. Electron ionization (El), chemical ionization (Cl), electrospray ionization
(ESI), atmosphere pressure chemical ionization (APCI), fast atom/ion bombardment
(FAB), and matrix-assisted laser desorption/ionization (MALDI) are common
ionization techniques (Johnstone & Rose, 1996; Burlingame & Carr, 1996). For the
analyzer/mass filter, quadrupole/triple-quadrupoles, magnetic sector, ion trap, and
time of flight (TOF) are widely used. Detection and recording are often achieved by
coupling an electron multiplier with a high-speed computer (Siuzdak, 1996).
The biggest advantage in utilizing mass spectrometry as an analytical tool is
that it provides confirmation information on the analytes. Unlike UV or other
spectrophotometer detectors, mass spectrometers do not require analytes to have any
chromophores or special properties. Any ionizable chemical can be detected by the
mass spectrometer. Another advantage o f mass spectrometry is that it provides more
than just “detection.” A good mass spectrum often provides important information
such as molecular weight and special characteristic fragments o f the analytes. If the
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appropriate mass spectrometer and separation technique are used, the molecular
structure o f unknowns can be determined and confirmed. Because o f the unique
advantages o f mass spectrometry, it has become a very useful tool for chemical
analysis, especially when complicated sample matrices are encountered (e.g., the
biological and environmental samples) (Siuzdak, 1996).
In general, HPLC, GC, and CE are often coupled with the mass spectrometer
as inlets and to provide separation prior to mass spectrometer analysis. HPLC is by
far the most favored inlet for bio-analysis. It has the capability o f handling large
molecules, provides better separation for special compounds, larger sample
capacity, and most importantly, it does not cause thermal degradation o f the
analytes. Because o f those advantages, liquid chromatography/mass spectrometry
(hereafter referred to as LC/MS) has become increasingly popular among analytical
chemists. Today, the application of LC/MS has become widely used. Application
ranges from trouble-shooting, research work, and even routine quality control
duties.
The most advanced LC/MS is the LC/tandem mass spectrometer
(LC/MS/MS) with atmospheric pressure ionization (ESI and APCI). The
electrospray ionization (ESI) model transforms ions in solution into ions in the gas
phase. In ESI, ions are produced and analyzed as follows:
1. The sample solution enters the ESI capillary, to which a high voltage is
applied.
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2. The ESI capillary sprays the sample solution into a fine mist o f droplets
(aerosol) that are electrically charged at their surface. The electrical charge density
at the surface o f the droplets increases as solvent evaporates from the droplets.
3. The charge density at the surface o f droplets increases to a critical point
(Rayleigh stability limit) and then becomes divided into smaller droplets because
the electrostatic repulsion is greater than the surface tension. The process is repeated
many times to form very small droplets.
4. Charged sample ions are ejected into the gas phase by electrostatic
repulsion and enter the mass spectrometer.
In atmospheric pressure ionization (APCI), ions are produced and analyzed
as follows:
1. The APCI sprays the sample solution into a fine mist o f droplets and is
vaporized in a high temperature tube.
2. A high voltage is applied to a needle located near the exit end o f the tube
and creates a corona discharge that forms reagent ions through a series o f chemical
reactions with solvent molecules and nitrogen nebulizating gas.
3. The reagent ions react with sample molecules to form ions and enter the
mass spectrometer.
A typical example o f the mass spectrometer is the quadrupole mass
spectrometer. Quadrupole mass analyzers have been used in conjunction with
electron ionization sources since the 1950s (Chapman, 1993). Electron ionization
coupled with quadrupole mass analyzers is employed in the most common mass
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spectrometers in existence today. Quadrupole mass analyzers have found new utility
in their capacity to interface with electrospray ionization. This interface has three
primary advantages. First, quadrupoles are tolerant o f relatively low vacuum
(~5><10 5 Torr), which is very suitable to electrospray ionization since the ions are
produced under atmospheric pressure conditions. Second, quadrupoles are now
capable o f analyzing compounds with m/z ratios (3000-4000), which is very useful
for bio-analysis. Finally, the cost o f a quadrupole analyzer instrument is lower
compared with other analyzers.
Considering these mutually beneficial features o f quadrupole analyzers, it is
not surprising that quadrupole instruments are widely used for LC/MS applications,
especially LC/MS/MS. There are other advantages o f utilizing quadrupole
instruments in chemical analysis. For example, the quadrupole analyzer is
independent o f ion velocity, therefore, the peak broadening on fragmentation seen
with sector instruments is absent when a quadrupole is used. A triple quadrupole is
able to provide unit mass resolution for both precursor and fragment ions and the
spectra are generally free from artifacts.
The most advanced quadrupole mass spectrometer is the triple quadrupole
tandem mass spectrometer. It is constructed by joining three quadrupole
analyzers/filters together. The first and third quadrupole serve as analyzer/filter and
the second quadrupole (radio frequency only) is designed to be the collision cell to
further break down the ions (usually by introducing argon or helium as collision
gases). This design offers advantages in resolution and sensitivity (signal to noise
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enhancement) for the study o f ion fragmentation as well as freedom from artifact
peaks (Chapman, 1993). As a result, independent mass analyzer/filters are available
which can select precursor and fragment ions for a fragmentation taking place in the
second quadrupole. The further fragment ions are called “daughter” ions (MS/MS).
Daughter ions provide valuable information for structure determination and because
o f the signal to noise enhancement it also serves as a very powerful tool for trace
sample or bio-sample analysis.
Analytical Approach
Our goal is to utilize LC/tandem mass spectrometry to develop a method to
use DNA adducts BaP-C8 Gua and BaP-N7Gua formation as bio-markers o f
exposure to carcinogens. A stable isotope internal standard method was developed
for our analysis. The use o f stable isotope analogues as internal standards for
quantitative LC/MS work has been adopted by researchers because o f the following
major advantages (Johnstone & Rose, 1996).
1. The stable isotope internal standard has similar/same chemical/ physical
properties o f the compound to be quantified; therefore, it compensates for any losses
during work-up by behaving identically towards extraction or purification.
2. The isotope internal standard is often co-eluted with the compound to be
quantified via chromatography; hence, it compensates for any variation o f the
instrumentation. For example, a slight variation in pressure in the ion source will
have the same degree o f effect on both analytes and internal standards. Therefore,
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the effect o f the magnitude for both signals is the same. Since only the ratio o f
analyte and internal standard is used, the result will not change.
3.

The difference in mass between standard and analyate can be easily

distinguished by mass spectrometry. It is especially useful for analyzing samples
with a complicated sample matrix. A carefully designed LC/MS/MS experiment
usually taking cares o f all the problems.
For our study, authentic standards (BaP-C8 Gua and BaP-N7Gua) and stable
isotope internal standards (dn-BaP-C 8 Gua and dn-BaP-N7Gua) were synthesized
by the electrochemical method and purified by liquid chromatography. In vitro and
in vivo methods were used to generate the bio-samples and the levels o f BaP-C8 Gua
and BaP-N7Gua in each sample were determined by our method.
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CHAPTER HI
MATERIALS AND METHODS
Materials
Benzo[a]pyrene, calf thymus DNA, and horseradish peroxidase type II were
purchased from Sigma Chemical Company (St. Louis, MO) and the N-2hydroxyethylpiperazine-N’-2-ethanesulfonic acid (HEPES) was purchased from
United State Biochemical Corporation (Cleveland, OH). Benzo[a]pyrene-di2 was
purchased from Cambridge Isotope Laboratories (Andover, MA) and
deoxyguanosine monohydrate was purchased from Fluka Chemical Company (St.
Louis, MO). All solvents used for LC/MS and LC/MS/MS analysis were HPLC
grade and purchased from Fisher Scientific (Itasca, IL). C-18 Sep-Pak cartridges
were purchased from Millipore (Bedford, MA).
Instruments
The electrochemical synthesis device was assembled in our laboratory. It
consisted o f a potentiostat (A.R.F. Product) (Boulder,CO), a calomel reference
electrode, and two platinum electrodes. A lOOmL Pyrex beaker was used as the
synthesis cell and a magnetic stir bar was used for sample stirring. Nuclear magnetic
resonance spectra (NMR) were determined on a JEOL Eclipse 400 FT NMR
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spectrometer (Peabody, MA). The LC/tandem mass spectrometer system used was a
Micromass Quattro II triple-quadrupole mass spectrometer (Wythenshawe, UK)
coupled with a Waters 2696 multisolvent delivery system, Waters 2487 dual
wavelength UV detector, and an auto injector (Milford, MA). The HPLC system
used for sample purification was a Waters HPLC system equipped with Waters 600MS multisolvent delivery system and manual injector (Milford, MA) coupled with a
Hewlett Packard 1040A Photodiode array detector (Palo Alto, CA). The HPLC
system used for evaluating the homogeneity and potency o f benzo[a]pyrene in
dosed feed was a Hewlett Packard 1090 HPLC system coupled with a Photodiode
array detector (Palo Alto, CA). The rotatory shaker used for feed preparation was
from Lortone inc. (Seattle, WA). The LC/tandem mass spectrometer system used for
APCI (confirmation) was a Finnigan LCQ mass spectrometer (San Jose, CA)
coupled with a Hewlett Packard 1090 HPLC system (Palo Alto, CA).
Synthesis o f BaP-C8 Gua and BaP-N7Gua
The Rogan and Cavialier electrochemical synthesis method (Rogan et al.,
1988) was used for preparing BaP-C8 Gua and BaP-N7Gua. The electrochemical
synthesis device was assembled in our laboratory.
In a typical preparation, DMF (20mL, dried by sodium sulfate and degassed)
containing 0.5 M KCIO4 as electrolyte was pre-electrolyzed at +1.45V verses the
standard calomel reference electrode for 30 minutes with argon purging. The pre
dried (80 °C under vacuum for 24 hours) deoxyguancsine monohydrate (1 mmol)
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and benzo[a]pyrene(0 .1 mmol) were added to the solution and the resulting solution
was stirred until all materials dissolved. The bubbling o f argon was stopped and the
electrode potential was gradually raised from zero to 1.1V verses the standard
calomel reference electrode (current is usually around 20-30 mA). The reaction was
stopped when the current dropped to around 1 mA(usually after 2 hours). The dark
brown, crude solution was then transferred to a separatory funnel along with

100

mL 0.05% formic acid in Milli-Q water. The solution was extracted three times with
150 mL o f CHCI3 . The combined extract was dried on a rotatory evaporator and redissolved in 5 mL DMSO. A C l 8 Sep-Pak cartridge was conditioned by first eluting
with 6 mL o f acetonitrile and then followed by 6 mL o f water. Approximately 0.25
mL o f the DMSO solution was then loaded on a pre-conditioned C-18 Sep-Pak
cartridge and washed with 10 mL of water followed by 5 mL o f 10% methanol in
water to remove unreacted deoxyguanosine. Adducts were eluted with 15 mL o f
50/50 (% v/v) acetone: methanol (both containing 0.1% formic acid) and collected.
The procedure was repeated for the remaining DMSO solution. All adduct fractions
were combined and dried on a rotatory evaporator and then re-dissolved in 5 mL o f
DMSO for further HPLC purification.
HPLC purification o f BaP-C8 Gua and BaP-N7Gua was conducted using a
Waters HPLC system equipped with a Waters 600-MS multisolvent delivery system
and manual injector, and a Hewlett Packard 1040A DAD detector set to monitor the
absorbance at 300nm. Solvent A was 0.1% formic acid in acetonitrile and solvent B
was 0.1% formic acid in Milli-Q water. Two HPLC steps were used for purifying
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the DNA adducts. First purification step was performed on a semi-preparative
reversed-phase C-18 column (250 x 9.4 mm, 5 pm) (Phenomenex, Terrance, CA). In
general, 250 pL o f the DMSO (post Sep-packs) solution was injected onto the
column and eluted with the following linear gradient program at a flow rate o f 2 . 0
mL/min: 0 minute, 20% A; hold for 5 minutes; 75 minute, 100% A; hold for 10
minute; 85.1 minute, 20% A. The BaP-C 8 Gua eluted at 37 minutes and BaP-N7Gua
eluted at 42minutes. BaP-C 8 Gua and BaP-N7Gua were collected individually and
dried under vacuum. The procedure was repeated for the remaining samples.
Finally, all BaP-C8 Gua fractions and all BaP-N7Gua fractions were combined
respectively and dried under vacuum. Approximately 0.5 mL o f DMSO was added
to each sample to dissolve adducts for the second HPLC purification.
For the second purification step, a Zorbax SB-CN column (250 x 4.6mm,
5pm) (Hewlett Packard, CA) and a linear gradient were used for both BP-C8 Gua
and BaP-N7Gua samples. Typically,

20

pL o f either DMSO (BaP-C8 Gua orBaP-

N7Gua first purification step) solution was injected onto the column and eluted with
the following linear gradient program at a flow rate o f 1.0 mL/min: 0 minute, 30%
A; hold for 5 minutes; 55 minute, 100% A; hold for 10 minutes; 65.1 minute, 30%
A (hereafter referred to as Gradient 20 HPLC method). The BaP-C 8 Gua eluted at 15
minutes and BaP-N7Gua eluted at 19 minutes. Each adduct was collected and dried
under vacuum and the procedure was repeated for the remaining samples.
A total o f eight preparations o f crude mixture were made and purified by
following the above procedure. The identity o f BaP-C8Gua and BaP-N7Gua were
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confirmed by NMR, LC/MS (ESI), LC/MS/MS (ESI), and LC/MS (APCI). Typical
LC chromatograms are shown in Figure 5. The U V profile from DAD is shown in
Figure 6 .
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Figure 5.

LC Chromatograms. ([From top to bottom] Reaction Mixture; LC
chromatogram o f BaP-C 8 Gua; LC chromatogram o f BaP-N7Gua. The
Gradient 20 HPLC Method was used to run all samples [Zorbax SB-CN
column 250 x 4.6 mm, 5 pm]).
Synthesis ofBaP-C 8 Gua-dn and BaP-N7Gua-dn

The synthesis and purification procedures used here were the same as
preparing BaP-C 8 Gua and BaP-N7Gua. The only difference was to use o f
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Figure 6 . (From left to right) BaP-C8 Gua UV Profile From DAD; BaP-N7Gua UV
Profile From DAD.

benzo[a]pyrene-di2 (twelve deuterated)in place o f benzo[a]pyrene in the synthesis
and run on a smaller scale each time.
In a typical preparation, DMF (10 mL, dried by sodium sulfate and
degassed) containing 0.5 MKCIO 4 as electrolyte was pre-electrolyzed at +1.45 V
versus the standard calomel reference electrode for 30 minutes with argon bubbling.
The pre-dried (80 °C under vacuum for 24 hours) deoxyguanosine monohydrate (0.5
mmol) and benzo[a]pyrene-di2 (0.05 mmol) were added to the solution and the
resulting solution was stirred until all materials dissolved. The bubbling o f argon
was stopped and the electrode potential was raised from 0 to 1.1V verses the
standard calomel reference electrode (current was approximately 20-30 mA). The
reaction was stopped when the current dropped to approximately 1mA (usually
around 2 hours). The dark brown, crude solution was then transferred to a
separatory funnel along with 50 mL 0.05% formic acid in Milli-Q water. The
solution was extracted three times 25 mL o f CHCI3 . The combined extract was dried
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on a rotatory evaporator and re-dissolved in 5 mL DMSO. A C l 8 Sep-Pak cartridge
was conditioned by first eluting with 6 mL o f acetonitrile and then followed by

6

mL o f water. Approximately 0.25 mL o f the DMSO solution was loaded on a pre
conditioned C-18 Sep-Pak cartridge and washed with lOmL of water followed by 5
mL o f 10% methanol in water to remove unreacted deoxyguanosine. Adducts were
eluted with 15 mL o f 50/50 (% v/v) acetone: methanol (both with 0.1% formic acid)
and collected. The procedure was repeated for remaining DMSO solution. All
adduct fractions were combined and dried on a rotatory evaporator and then
redissolved in 5 mL o f DMSO for further HPLC purification.
HPLC purification ofBaP-C 8 Gua-dn and BaP-N7Gua- d n was
accomplished using the same Waters HPLC system. It is Waters HPLC system
equipped with a Waters 600-MS multisolvent delivery system and manual injector,
and a Hewlett Packard 1040A DAD detector set to monitor the absorbance at 300
nm. Solvent A was 0 . 1 % formic acid in acetonitrile and solvent B was 0.1% formic
acid in Milli-Q water. Two HPLC methods were used for purifying the DN A
adducts. First purification step was done on a semi-preparative reverse-phase C-18
column (250 x 9.4 mm, 5 pm) (Phenomenex, Terrance, CA). In general, 250 pL of
the DMSO (post Sep-packs) solution was injected onto the column and eluted with
the following linear gradient program at a flow rate o f 2.0 mL/min: 0 minute, 20%
A; hold for 5 minutes; 75 minute, 100% A; hold for 10 minutes; 85.1 minute, 20%
A The BaP-C 8 Gua-dn eluted at 37 minutes and BP-N7Gua-dn eluted at
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42minutes, BaP-C 8 Gua-dn and BaP-N7Gua-dn were collected individually and
dried under vacuum. The procedure was repeated for the remaining samples.
Finally, all BaP-C 8 Gua-dn fractions and all BaP-N7Gua-dn fractions were
combined respectively and dried under vacuum. Approximately 0.5 mL o f DMSO
was added to each sample to dissolve adducts for the second HPLC purification.
For the second purification step, a Zorbax SB-CN column (250 x 4.6 mm, 5
Jim) (Hewlett Packard, CA) and a linear gradient were used for both BaP-C8 Guad n and BaP-N7Gua-dn samples. Typically, 20 jiL o f either DMSO (BaP-C8 Guad n or BaP-N7Gua-di i first purification) solution was injected onto the column and
eluted with the Gradient 20 HPLC method. The BaP-C8 Gua-di i eluted at 15
minutes and BaP-N7Gua-dn eluted at 19 minutes. The retention times ofBaPC8 Gua-di i and BaP-N7Gua-dj i on both HPLC assays are almost identical with
BaP-C 8 Gua and BaP-N7Gua. Each adduct was collected and dried under vacuum
and the procedure was repeated for the remaining samples.
A total o f three batches were made and purified subsequently and 0.3 mg
BaP-C 8 Gua-dn and 0.9 mg ofBaP-N7Gua-dnwere obtained.

MS/MS/MRM (Multiple Reaction Monitoring) Optimization
Quantitative analysis o f BaP-C 8 Gua and BaP-N7Gua was performed in the
LC/MS/MS/MRM mode. The mass spectrometer was operated in the positive ion
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ESI mode. Tuning o f the ESI source and optimizing the MS/MS parameters were
carried out using synthetic BaP-C8 Gua and BaP-N7Gua standards. Standards were
first dissolved in DMSO and then diluted with 45/45/10 (% v/v/v) acetonitrile:
methanol: 2 % formic acid in water and then induced by syringe pump at a flow rate
o f 3 to 5 pL/min. ESI interface and mass spectrometer were optimized to obtain
maximum sensitivity. The electrospray current was optimized by monitoring the ion
intensity o f MH+ (m/z 402) from 2.0 kV to 5.0 kV for both adducts. The collision
energy was optimized by monitoring the intensity o f m/z 277 (major fragment) for
both adducts. For the collision energy optimization, the first quadrupole o f the
instrument was set only to pass the MH+ at m/z 402 for both adducts. The product
ions (daughters) were separated in the third quadrupole. Argon was used as the
collision gas, with a gas cell pressure o f ~2.5xl0

_3

mbar. The collision energy was

studied from 0 V to 200 V.
LC/MS/MS/MRM (Multiple Reaction Monitoring) Method
For the quantitative study of adducts, a LC/MS/MS/MRM (mutiple reaction
monitoring) method was developed and used. For the mass spectrometer, the first
quadrupole o f the instrument was set only to pass the MH+ at m/z 402 for both
adducts and m/z 413 for both deuterated internal standards. The collision induced
fragmentation that occurred at the second quadrupole. The product ions (daughters)
were separated in the third quadrupole. Argon was used as the collision gas, with a
gas cell pressure o f ~2.5xl0

.3

mbar. The collision energy was set at 40 V. The
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quantitative analysis o f adducts was done by MS/MS/MRM mode by monitoring
their daughter ions. For the authentic adducts, (BaP-C8 Gua and BaP-N7Gua) m/z
402

277 and m/z 402

360 transitions were monitored. For the internal

standards (BaP-C8 Gua-dn and BaP-N7Gua-dn) m/z 413 -> 287 and m/z 413->
371 transitions were monitored.
For the HPLC, a Zorbax SB-CN column (250 x 4.6 mm, 5 Jim) fitted with a
Zorbax SB-CN guard column was used for all the sample analysis. The flow rate
was 0.7 mL/min. Formic acid, 0.2% in water, was used as solvent A and 0.2%
formic acid in acetonitrile was used as solvent B. A linear gradient was run as
follows: 0 minutes, 48% B; 5 minutes, 48% B; 20 minutes, 100% B; 25 minutes,
100% B; 25.1 minutes, 48% B; 30 minutes, 48% B. The BaP-C 8 Gua and BaPC8 Gua-di i were co-eluted at approximately 7 minutes, and the BaP-N7Gua and
BaP-N7Gua-di i were co-eluted at approximately 10 minutes under the above
conditions.
For a typical analysis, 10 pL of sample was injected. A standard curve was
constructed by replicate analysis o f solutions containing BaP-C8 Gua and BaPN7Gua standards from 1 to 32 ng per injection and the internal standards BaPC8 Gua-di i and BaP-N7Gua-di iat 2 ng per injection in all o f the solutions.
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Adducts Stability Evaluation and Method Suitability
Several spike and recovery studies were performed by addition o f the
authentic standards at various sample preparation stages to assess the method
validity, adduct stability, and procedure efficiency. Different types o f bio-samples
were used to verify the method’s ruggedness and robustness.
The adduct stability and the Sep-Pack procedure efficiency were
demonstrated by treating adducts at extreme conditions, spiking the internal
standards into the post Sep-Pack fraction, and assaying for recovery. Duplicate
samples were prepared for each level o f the study. The samples were prepared by
spiking 15, 75, 150, 300, and 450ng o f authentic adducts into separate test tubes
with 2 mL o f 0.02 N HCi. The spiked concentrations were equal to 1, 5, 10, 20, and
30 ng on column based on a final volume of 150 pL and 10 pL injection. The
solutions were hydrolyzed at 75 °C for 1.5 hours. After cooling, each sample was
neutralized to pH 7.0 by addition o f NaOH. The C18 Sep-Pak cartridges were
activated by first rinsing with

6

mL o f acetonitrile followed by

6

mL o f purified

water. Each sample was then loaded onto a separate cartridge and washed with 5
mL o f purified water. Adducts were eluted with 3 mL o f methanol. The methanol
fraction for each sample was collected separately and spiked with 30 ng o f the
deuterated internal standards (both BaP-C 8 Gua-dn and BaP-N7Gua-dn). The final
methanol fraction was dried under ultrapure nitrogen. Finally, the residue was
redissolved in 150 pL o f DMSO for LC/MS/MS/MRM analysis.
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The method validation was demonstrated by measuring adduct levels in rat
liver DNA samples spiked with a known amount of authentic standards. Duplicate
samples were prepared for each spiked concentration level. Rat liver D N A was
obtained as described in the protocol provided by Life Technologies Co. For each
spiked sample, 1.0 gram o f liver was minced and homogenized in 30 ml o f dnazol
reagent using a hand held glass homogenizer for approximately 30 seconds. The
solution was then centrifuged at

1 0 ,0 0 0

x g for

10

minutes to remove insoluble

tissue fragments, RNA, and excess polysaccharides. The top layer was transferred to
a new tube and the D N A was precipitated by the addition o f a half volume o f
absolute ethanol. D N A was recovered by centrifugation at 1700 x g for 2 minutes
and washed three times with 70% ethanol. The DNA pellet was air dried briefly,
dissolved in 8 mm sodium hydroxide solution and the ph was then adjusted to 7.0
with HEPES and centrifuged at

1 0 ,0 0 0

x g for 2 minutes to remove any impurities.

The DNA was then re-precipitated by addition o f ethanol and recovered by
centrifugation at 1700 x g for 3 minutes. The DNA pellet was then briefly air dried,
and then redissolved in

8

mm sodium hydroxide solution and the ph was adjusted to

7.0 with HEPES. The quantity o f D N A was estimated by reading the absorbance
(1AU = 50 pg DNA/ml) at 260 nm. The purity of the D N A was estimated by
scanning the UV spectrum from 200 to 400 nm and calculating the 260/280 ratios.
Typical yield o f each preparation was approximately 3.7 to 4.1 mg of DNA per
1000 mg o f liver tissue (3.7 ~ 4.1 pg/mg).
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For each spike, 15, 75, 150, 300, and 450 ng o f adducts were added
separately into individual DNA solutions (approximately 4 mg equal to prepare
from 1 g o f liver tissue). The spiked levels were equal to 1, 5, 10, 20, and 30 ng on
column based on a final sample volume o f 150 pL and 10 jxL injection per sample.
The ph of each spiked solution was adjusted to approximately 2.5 with hcl and
hydrolyzed at 75 °C for 45 minutes (Citti, Gervasi, Turchi, Bellucci, & Bianchini,
1984; Dong & Jeffrey, 1991; Josephy, 1997; McCull et al., 1999). After cooling,
each sample was neutralized to a ph o f 7.0 by the addition o f sodium hydroxide
solution and then spiked with 30 ng o f the deuterated internal standards (both bapC8 Gua-dn and bap-N7Gua-di i). The C18 Sep-Pak cartridges were activated by first
rinsing with 6 ml o f acetonitrile and followed by 6 ml o f purified water.
Approximately 1/3 of the sample was then load on a cartridge and washed with 5 ml
o f purified water. Adducts were eluted with 3 ml of methanol. The procedure was
repeated for each the sample and methanol fractions were then combined and dried
under ultrapure nitrogen. Finally, the residue was redissolved in 150 pL o f DMSO
for LC/MS/MS/MRM analysis.
Blank rat liver DNA samples were prepared by following the procedure
described above. Neither authentic nor internal standards were added for the blank
preparations in order to assess the possible bias.
The method suitability for different bio-samples was demonstrated by
measuring adduct levels in rat urine and feces samples spiked with a known amount
o f authentic standards. For the rat urine experiment, duplicate samples were
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prepared for each spiked concentration. The spiked samples were prepared by the
addition o f 15, 75, 150, 300, and 450 ng o f adducts respectively onto separate 5 ml
aliquots o f blank rat urine and then prepared for analysis by the following
procedure.
Briefly, the urine sample was extracted with five 5 ml aliquots o f
chloroform. The protein precipitated from the extraction was transferred into a
separate tube and extracted with five 5 ml aliquots o f acetonitrile. The acetonitrile
and chloroform extracts were combined. The combined organic extract was spiked
with 30 ng of the deuterated internal standards (both bap-C8 Gua-di i and bapN7Gua-di i) and then dried under ultrapure nitrogen. The residue was redissolved in
150" pL DMSO and the recovery was evaluated by LC/MS/MS/MRM. The spiked
levels were equal to 1, 5, 10, 20, and 30 ng on column based on a final sample
volume o f 150 pL and 10 pL injection per sample. Blank urine samples were
prepared by following the procedure described above. Neither authentic nor internal
standards were added for the blank preparations in order to assess the possible bias.
For the rat feces experiment, duplicate samples were prepared for each
spiked concentration. Rat feces was first dried at 80 °C with an in-house vacuum for
24 hours and then pulverized by mortar and pestle. The spiked samples were
prepared by addition o f 15, 75, 150, 300, and 450 ng of adducts respectively onto
separate

1 .0

g of dried feces powder and prepared for analysis by the following

procedure. Briefly, each spiked feces sample was dried at 80 °C with an in-house
vacuum for 24 hours. The dried sample was extracted with three 5 ml aliquots of

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

chloroform (5 hours shaking on a shaker for each fraction) followed by three 5 ml
aliquots o f acetone (one hour shaking for each fraction). The chloroform and
acetone extracts were combined. The combined organic extract was spiked with 30
ng o f the deuterated internal standards (both bap-C8 Gua-dn and bap-N7Gua-di i)
and dried under ultrapure nitrogen. The residue was redissolved in

1 .0

ml o f 50/50

(% v/v) DMSO: acetone. The C18 Sep-Pak cartridges were activated by first rinsing
with 6 ml o f acetonitrile followed by 6 ml o f purified water. Approximately 1/3 o f
the sample was then loaded on a cartridge and washed with 5 ml o f purified water.
Adducts were eluted with 3 ml o f methanol. This procedure was repeated for the
rest o f the sample and methanol fractions were combined and dried under ultrapure
nitrogen. Finally, the residue was redissolved in 150 pL of DMSO for
LC/MS/MS/MRM analysis.
The spiked levels were equal to 1, 5, 10, 20, and 30 ng on column based on a
final sample volume o f 150 pi and 10 pi injection per sample. Blank feces samples
were prepared by following the procedure described above. Neither authentic nor
internal standards were added for the blank preparations in order to assess the
possible bias.
In Vitro Sample Preparation
The in vitro experiment was performed by following a slightly revised
procedure o f Rogan and Cavalieri (Rogan et al., 1988). Rat liver D N A (isolated and
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purified in our lab) and calf thymus DN A (purchased from Sigma-AIdrich Co.) were
used for our in vitro experiment.
Rat liver DNA was obtained as described in the protocol provided by Life
Technologies Co. Briefly,

1 .0

gram o f liver was minced and homogenized in 30 ml

o f dnazol reagent using a hand held glass homogenizer for approximately 30
seconds (about 10 strokes). The solution was centrifuged at 10,000 x g for 10
minutes to remove insoluble tissue fragments, RNA, and excess polysaccharides.
The top layer was transferred to a new tube and the DNA was precipitated by the
addition o f a half volume o f absolute ethanol. DNA was recovered by centrifugation
at 1700 x g for 2 minutes and washed three times with 70% ethanol. The DNA
pellet was air dried briefly, dissolved in

8

mm sodium hydroxide solution and the ph

was adjusted to 7.0 with HEPES and centrifuged at 10,000 x g for 2 minutes to
remove any impurities. The DNA was re-precipitated by addition o f ethanol and
recovered by centrifugation at 1700 x g for 3 minutes. The DNA pellet was briefly
air dried, and redissolved in 8 mm sodium hydroxide solution and the ph was
adjusted to 7.0 with HEPES. The quantity o f DNA was estimated by reading the
absorbance (1 AU=50 jag DNA/ml) at 260 nm. The purity o f the DN A was estimated
by scanning the UV spectrum from 200 to 400 nm and calculating the 260/280
ratios. Typical yield of each preparation was approximately 3.7 to 4.1 mg o f DNA
per lOOOmg o f liver tissue (3.7 ~ 4.1 |ig/mg). A total o f 150 mg o f rat liver DNA
was prepared by following the above procedure.
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For each o f the in vitro experiment, 50 mg o f DNA was dissolved in 100 ml
o f 60 mm sodium hydroxide solution and the ph was adjusted to 7.0 with
phosphoric acid. A solution o f 0.1 mg/ml Horseradish peroxidase (HRP) (typeii,
Sigma-Aldrich) containing 0.5 mm o f hydrogen peroxide was added.
Benzo[a]pyrene was added at

10

mm by spiking with a 2.5 mg/ml stock DMSO

solution. The above solution was purged with Argon, sealed, and incubated at 37 °C
for a period of 30 minutes. The solution was cooled to room temperature and the
procedure was repeated once with same amount o f HRP, H2 O2 , and benzo[a]pyrene
and incubated at 37 °C for another 30 minutes. At the end of the reaction, DNA was
precipitated and collected by the addition o f 2 volumes of ethanol followed by
centrifugation at 1700 x g for 2 minutes. For the depurinating adducts, the
supernatant was used and the DNA pellet was extracted with three 5 ml aliquots of
chloroform. The supernatant and chloroform extracts were pooled and evaporated
under vacuum and the soluble residue was redissolved in 1 ml o f 50/50 (% v/v)
DMSO: meoh, to which 30 ng o f deuterated internal standards were then added. The
C18 Sep-Pak cartridges were activated by first rinsing with 6 ml o f acetonitrile
followed by 6 ml o f purified water.
Approximately one quarter of the above sample (0.25 ml) was load on a
cartridge and washed with 5 ml o f purified water. Adducts were eluted with 3 ml o f
methanol. This procedure was repeated for the remaining sample and methanol
fractions were combined and dried under ultrapure nitrogen. Finally, the residue was
redissolved in 150 jil o f DMSO for LC/MS/MS/MRM analysis.
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The stable DNA adducts were released by thermal/acid hydrolysis (Citti et
al., 1984; Dong & Jeffrey, 1991; Josephy, 1997; McCull et aL, 1999). The DNA
was dissolved in 25 mm naoh. The ph o f the solution adjusted to approximately 2.5
with hcl and hydrolyzed at 75 °C for 45 minutes. After cooling, the sample was
neutralized to ph o f 7.0 by addition o f naoh and spiked with 30 ng of the deuterated
internal standards. The C l 8 Sep-Pak cartridges were activated by first rinsing with 6
ml o f acetonitrile followed by 6 ml o f purified water. Approximately 1/3 o f the
above sample was loaded on a cartridge and washed with 5 ml of purified water.
Adducts were eluted with 3 ml o f methanol. This procedure was repeated for the
rest of the sample and methanol fractions were combined and then dried under
ultrapure nitrogen. Finally, the residue was redissolved in 150 pi of DMSO for
LC/MS/MS/MRM analysis.
In order to assess the possible interference and bias, blank samples were
prepared. Both calf thymus D N A and rat liver blanks were prepared by following
the procedure described above, but without the addition o f benzo[a]pyrene for the
reaction. Internal standards were not added in final sample preparations.
In Vivo Rat Experiment
For the in vivo rat study, a total of 36 1 -month post weaning male Fisher 344
rats were obtained (Charles River, MI) for this study. The rats were put on an inhouse basal diet and water a d lib for 2 weeks prior to use. They were assigned
randomly into one control group and three treatment groups, with 9 rats in each
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group. Three exposure levels for benzo[a]pyrene were chosen and chronic dietary
(feed) dosing was use for the study. Benzo[a]pyrene was added in the rat feed
(pellet) for the dosing groups at three different concentrations;

1

mg/g ( 1 0 0 0 ppm),

0.1 mg/g (100 ppm), and 0.01 mg/g(10 ppm). For the feed preparation, a general
procedure was developed and followed. Briefly, a 20 mg/ml benzo[a]pyrene stock
solution was made by dissolving benzo[a]pyrene in toluene. In a 4000 ml
polypropylene bottle, 2000 g of pellet feed, 300 ml o f 95% ethanol, and aliquot o f
stock solution were added and sealed. The mixture was then put on a rotating shaker
and rotated for about 4 hours until all liquid soaked into the feed. The pellet was
then dried in the vacuum oven at 80 °C with in-house vacuum for 48 hours to
evaporate the solvent. The same process was used for preparing the feed for the
control group except that no benzo[a]pyrene was added.
A HPLC assay was run on each feed sample to ensure the homogeneity and
potency o f benzo[a]pyrene in feed before it was used. For the HPLC assay, a
Hewlett Packard 1090 HPLC system equipped with a DAD detector and a Zorbax
SB-C8 column (150 x 4.6 mm, 5 pm) (Hewlett Packard, CA) were used for all the
sample analysis. The detector was set to monitor the absorbance at 300 nm for
benzo[a]pyrene. The flow rate was 1.0 ml/min and the injection volume was 10 pL.
Formic acid (0.2%) in water was used as solvent A and 0.2% formic acid in
acetonitrile was used as solvent B. A linear gradient was run as follows: 0 min, 60%
A, hold for 1 min; 7 min, 100% A, hold for 3 min; 10.1 min, 60% A
Benzo[a]pyrene eluted at 7 .1 minutes. For the HPLC sample preparation, briefly, at

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

each dose level, 2 to 5 grams o f dosed feed was soaked in diluent containing
70/20/10 (% v/v/v) ACN: meoh: acetone with constant shaking for 24 hours and
then filtered through a 0.22 pun filter. A calibration curve was made by analyzing 4
levels o f benzo[a]pyrene standards in triplicates via HPLC.
For each rat, weekly body weight and daily feed consumption were recorded
for the entire dosing period in order to calculate the actual dosage on animal. At the
end o f each dosing period (2, 4, and 8 weeks), 3 rats from each group were
euthanatized and the livers were excised for the dose response analysis. Excised
livers were immediately frozen in liquid nitrogen and stored at —70 °C until analysis.
For the in vivo rat liver DNA adducts analysis, the protocol provided by Life
Technologies Co. was used. Briefly, 1.0 gram o f liver was minced and homogenized
in 30 ml of dnazol reagent using a hand held glass homogenizer for approximately
30 seconds (about 10 strokes). The solution was then centrifuged at 10,000 x g for
10 minutes to remove insoluble tissue fragments, RNA, and excess polysaccharides.
The top layer was transferred to a new tube and the DNA was precipitated by the
addition of a half volume o f absolute ethanol. DNA was recovered by centrifugation
at 1700 x g for 2 minutes and washed three times with 70% ethanol. The DNA
pellet was air dried briefly, dissolved in 8 mm sodium hydroxide solution and the ph
was then adjusted to 7.0 with HEPES and centrifuged at 10,000 x g for 2 minutes to
remove any impurities. The DNA was re-precipitated by addition o f ethanol and
recovered by centrifugation at 1700 x g for 3 minutes. The D N A pellet was briefly
air dried, and then redissolved in 8 mm sodium hydroxide solution and the ph was
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adjusted to 7.0 with HEPES. The quantity o f DNA was estimated by reading the
absorbance (1AU = 50 pg DNA/ml) at 260 nm. The purity of the D N A was
estimated by scanning the UV spectrum from 200 to 400 nm and calculating the
260/280 ratios. Typical yield o f each preparation was approximately 3.7 to 4.1 mg
o f DNA per 1000 mg o f liver tissue (3.7 —4.1 jig/mg).
The stable DNA adducts were released by thermal/acid hydrolysis (Citti et
al., 1984; Dong & Jeffrey, 1991; Josephy, 1997; McCull et al., 1999). The ph o f the
above DNA solution was adjusted to approximately 2.5 with hcl and hydrolyzed at
75 °C for 45 minutes. After cooling, the sample was neutralized to ph o f 7.0 by
addition o f naoh and spiked with 30 ng o f the deuterated internal standards. The
C18 Sep-Pak cartridges were activated by first rinsing with 6 ml o f acetonitrile
followed by 6 ml o f purified water. Approximately 1/3 of the above sample was
loaded on a cartridge and washed with 5 ml o f purified water. Adducts were eluted
with 3 ml o f methanol. This procedure was repeated for the rest o f the sample and
methanol fractions were combined and then dried under ultrapure nitrogen. Finally,
the residue was redissolved in 150 pL o f DMSO for LC/MS/MS/MRM analysis.
In Vivo Fish Experiment
For the in vivo fish study, a total o f 53 4 to

6

inches bluegill fish were

obtained (Minnesota Muskies Farm, Brandon, MN) for this study. They were
assigned randomly into one control group and three treatment groups, with 13 to 14
fish in each group. For each group, fish were put in a 40 gallon tank with oxygen-
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saturated and dechlorinated water at room temperature. A flow-though system was
used to ensure the freshness o f water. The fish were kept on an in-house diet 2
weeks prior to use. Three exposure levels for benzo[a]pyrene were chosen and
chronic dietary (feed) dosing was used for the study. Benzo[a]pyrene was added to
the feed (pellet) for the dosing groups at three different concentrations;

1

mg/g

(1000 ppm), 0.1 mg/g (100 ppm), and 0.01 mg/g (10 ppm). For the feed preparation,
a general procedure was developed and followed. Briefly, a 20 mg/ml
benzo[a]pyrene stock solution was made by dissolving benzo[a]pyrene in toluene.
In a 1000 ml polypropylene bottle, 200 g o f pellet feed, 30 ml o f 95% ethanol, and
aliquot o f stock solution were added and sealed. The mixture was then put on a
rotating shaker and rotated for about 4 hours until all liquid soaked into the feed.
The pellet was then dried in the vacuum oven at 80 °C with in-house vacuum for 48
hours to evaporate the solvent. The same process was used for preparing the feed for
the control group except that no benzo[a]pyrene was added.
A HPLC assay was run on each feed sample to ensure the homogeneity and
potency o f benzo[a]pyrene in feed before it was used. For the HPLC assay, a
Hewlett Packard 1090 HPLC system equipped with a DAD detector and a Zorbax
SB-C 8 column (150 x 4.6 mm, 5 pm) (Hewlett Packard, CA) were used for all the
sample analysis. The detector was set to monitor the absorbance at 300 nm for
benzo[a]pyrene. The flow rate was 1.0 ml/min and the injection volume was 10 pL.
Formic acid (0.2%) in water was used as solvent A and 0.2% formic acid in
acetonitrile was used as solvent B. A linear gradient was run as follows: 0 min, 60%
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A, hold for 1 min; 7 min, 100% A, hold for 3 min; 10.1 min, 60% A.
Benzo[a]pyrene eluted at 7.1 minutes. For the HPLC sample preparation, briefly, at
each dose level, 2 to 5 grams o f dosed feed was soaked in diluent containing
70/20/10 (% v/v/v) ACN: meoh: acetone with constant shaking for 24 hours and
then filtered through a 0.22 pm filter. A calibration plot was made by analyzing 4
levels o f benzo[a]pyrene standards in triplicates via HPLC.
For the exposure, certain amounts o f feed were given to each group every
day for a period o f four weeks. At the end o f dosing period, all fish were
euthanatized and the livers were excised for the dose response analysis. Excised
livers were immediately frozen in liquid nitrogen and stored at —70 °C until analysis.
For the in vivo fish liver DNA adducts analysis, the protocol provided by
Life Technologies Co. was used. Briefly, 1.0 gram o f pool fish liver was minced and
homogenized in 30 ml of dnazol reagent using a hand held glass homogenizer for
approximately 30 seconds (about 10 strokes). The solution was then centrifuged at
10,000 x g for 10 minutes to remove insoluble tissue fragments, RNA, and excess
polysaccharides. The top layer was transferred to a new tube and the DNA was
precipitated by the addition o f a half volume o f absolute ethanol. DNA was
recovered by centrifugation at 1700 x g for 2 minutes and washed three times with
70% ethanol. The DNA pellet was air dried briefly, dissolved in 8 mm sodium
hydroxide solution and the ph was then adjusted to 7.0 with HEPES and centrifuged
at 10,000 x g for 2 minutes to remove any impurities. The DNA was then re
precipitated by addition o f ethanol and recovered by centrifugation at 1700 x g for 3
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minutes. The DNA pellet was then briefly air dried, and then redissolved in

8

mm

sodium hydroxide solution and the ph was adjusted to 7.0 with phosphoric acid. The
quantity o f DNA was estimated by reading the absorbance (1AU=50 pg DNA/ml) at
260 nm. The purity of the DNA was estimated by scanning the UV spectrum from
200 to 400 nm and calculating the 260/280 ratios. Typical yield of each preparation
was approximately 3.7 to 4.1 mg o f DNA per 1000 mg o f liver tissue (3.7 ~ 4.1
pg/mg).
The stable DNA adducts were released by thermal/acid hydrolysis (Citti et
al., 1984; Dong & Jeffrey, 1991; Josephy, 1997; McCull et al., 1999). The ph o f the
above DNA solution was adjusted to approximately 2.0 with hcl and hydrolyzed at
75 °C for 45 minutes. After cooling, the sample was neutralized to ph o f 7.0 by
addition o f naoh and spiked with 30 ng o f the deuterated internal standards. The
C18 Sep-Pack cartridges were activated by first rinsing with 6 ml o f acetonitrile
followed by 6 ml of purified water. Approximately 1/3 o f the above sample was
loaded on a cartridge and washed with 5 ml o f purified water. Adducts were eluted
with 2.5 ml o f methanol. This procedure was repeated for the rest o f the sample and
methanol fractions were combined and then dried under ultrapure nitrogen. Finally,
the residue was redissolved in 150 pi o f DMSO for LC/MS/MS/MRM analysis.
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CHAPTER IV
RESULTS AND DISCUSSION
Synthesis o f BaP-C 8 Gua and BaP-N7Gua
Electrochemical synthesis ofBaP-C 8 Gua and BaP-N7Gua was very
successful. The structures o f the synthesized adducts were elucidated by a
combination o f analytical instrumentation which includes NMR, MS (ESI and
APCI), and MS/MS. They perfectly matched the literature values (Rogan et al.,
1988).
The BaP-C8 Gua NMR spectrum shown excellent correlation with the
literature value. The absence o f both the C- 6 proton in the benzo[a]pyrene moiety
and C- 8 proton in the guanine moiety indicates that it is BaP-C8 Gua. Figure 7
shows the structure and numbering o f BaP-C 8 Gua.
The obtained NMR values were: 6.42(s, 2H, 2 -NH 2 [Gua]), 7.76-7.78(d, 1H,
5-H), 7.85 (m, 1H, 8 -H), 7.93-8.01(m, 2H.7-H, 9-H), 8.07-8.15(m, 2H, 2-H, 4-H),
8.26(d, 1H, 3-H), 8.46(d, 1H, 1-H), 8.58(d, 1H, 12-H), 9.33-9.37(m, 2H, 10-H,11H), 10.67(s, 1H, 1-H NH [Gua]), and 12.9(s, 1H, 7-H NH [Gua]).
The mass spectrum o f BaP-C8 Gua by electrospray showed a rational match
with literature values (Rogan et al., 1988). Mass spectrum o f BaP-C8 Gua by
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electrospray showed an (M+H)+ ion o f m/z 402. The mass spectrum o f BaP-C8 Gua
by ESI is shown in Figure 8 .
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Figure 7. Structure and Numbering o f BaP-C8 Gua.
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Figure 8 . Mass Spectrum o f BaP-C8 Gua by ESI.
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The molecular weight o f BaP-C8 Gua ((M+H)+ ion o f m/z 402) was
confirmed by APCI. The vaporization temperature was set at 450 °C and 5 pA
discharge current was used for APCI operation. The mass spectrum o f BaP-C8 Gua
by APCI is shown in Figure 9.
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Figure 9. Mass Spectrum ofBaP-C 8 Guaby APCI.

Electrospray (ESI) was used for all sample analysis instead o f APCI. The
high vaporization temperatures used for APCI cause a bio-sample’s matrix to
decompose, therefore, a very frequent ion source and compartment clean up would
have been needed if APCI was used.
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The MS/MS (ESI) spectrum o f BaP-C8 Gua was obtained by selectively
passing the m/z 402 ion through the first quadrupole, bombarding the ion by
inducing argon gas in the second quadrupole and then analyzing with the third
quadrupole. Upon collision (collision energy 35V), the 402 ion decomposes to
produce the most abundant ion at m/z 277 which is likely to be BaP-CN . The
greater abundance o f the m/z 277 in the spectrum o f BaP-C8 Gua as compared with
BaP-N7Gua is attributed to the greater stability o f BaP-CN+ versus BaP-NC*
(Rogan et al., 1988). The MS/MS spectrum o f BaP-C8 Gua by ESI is shown in
Figure 10.

Figure 10. Daughter Mass Spectrum (MS/MS) ofBaP-C 8 Gua by ESI. Collision
energy set at 35 V.
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The greater abundance o f the m/z 277 in the spectrum o f BaP-C 8 Gua
compared with BaP-N7Gua is very unique. Thus, it provides a rapid distinguishing
characteristic between BaP-C 8 Gua and BaP-N7Gua. In addition to the above, the
fragment ion o f m/z 385 is assigned as (M+H-NH 3)+ and m/z 360 is assigned as
(M+H- NH2 CN)+
The BaP-N7Gua NMR spectrum correlates very well with literature values.
In comparison with the standard spectrums in the literature (Rogan et al., 1988), the
absence of the C- 6 proton in the benzo[a]pyrene moiety and sharp singlet C- 8
proton in the guanine moiety indicate that it is BP-N7Giia. Figure 11 shows the
structure and numbering o f BaP-N7Gua.

12

1

Figure 11. Structure and Numbering o f BaP-N7Gua.
The obtained NMR values were: 6.32 (s, 2H, 2-NH2 [Gua]), 7.38 (d, 1 H, 5H), 7.57 (d, 1H, 7-H), 7.85 (t, IH, 8 -H), 7.96 (t, 1H, 9-H), 8.11-8.17 (m, 2H, 4-H, 2-
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H), 8.30 (d, 1H, 3-H), 8.36 (s, 1H, 8 -H [Gua]), 8.50 (d, 1H, 1-H), 8.62 (d, 1H, 12H), 9.38-9.40 (m, 2H, 10-H, 11-H), and 10.94 (s, 1H, 1H[NH Gua]).
The mass spectrum o f BaP-N7Gua by electrospray shows perfect correlation
with literature values as well (Rogan et al., 1988). The mass spectrum o f BaPN7Gua by electrospray showed an (M+H)+ ion o f m/z 402. The mass spectrum of
BaP-N7Gua by ESI is shown in Figure 12.
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Figure 12. Mass Spectrum o f BaP-N7Gua by ESI.

The molecular weight o f BaP-N7Gua ((M+H)+ ion of m/z 402) was
confirmed by APCI. The vaporization temperature was set at 450°C and 5 pA
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discharge current was used for APCI operation. The mass spectrum o f BaP-N7Gua
by APCI is shown in Figure 13.
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Figure 13. Mass Spectrum ofBaP-N7Gua by APCI.
The MS/MS spectrum (ESI) o f BaP-N7Gua was obtained by selectively
passing m/z 402 ion through the first quadrupole, bombarding the ion by inducing
argon gas in the second quadrupole and then analyzing with the third quadrupole.
Upon collision (collision energy was set at 35 V for this experiment in order to retain
some parent ion), the m/z 402 ion decomposes to produce abundant ions o f m/z 252
and 277. The m/z 252 ion is the benzo[a]pyrene moiety resulting from facile
protonation at the N 7 position o f BaP-N7Gua followed by a loss o f the neutral
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*+
guanine moiety. The m/z 277 ion it is likely to be BaP-NC . The MS/MS spectrum
o f BaP-N7Gua is shown in Figure 14.

BP-N7GUA DAUGHTER 14 (0.982) C n (C en,4,80.00, Ht); Sm (SG , 2x0.90); Sb (1,30.00); Sm (Mn. 2x0.75)
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Figure 14. Daughter Mass Spectrum (MS/MS) o f BaP-N7Gua by ESI. Collision
energy set at 35 V.

The higher abundance o f the m/z 252 daughter ions in the MS/MS spectrum
o f BaP-N7Gua compared with BaP-C8 Gua is very unique. Thus, it provides a rapid
distinguishing characteristic between BaP-C8 Gua and BaP-N7Gua. In addition to
the above, the fragment ion o f m/z 385 is assigned as (M+H-NH3 )+ and m/z 360 is
assigned as (M+H- NH2 CN)*
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Synthesis o f BaP-C8 Gua-di i and BaP-N7Gua-dn

Electrochemical synthesis ofBaP-C 8 Gua-dn and BaP-N7Gua-dn were
successful. The structures o f the synthesized adducts were elucidated by MS and
MS/MS. The BaP-C8 Gua-dn mass spectrum obtained by electrospray showed
excellent correlation with the spectrum o f BaP-C 8 Gua. The (M+H)+ ion o f m/z 413
is 11 units greater than BaP-C8 Gua which indicates to the 11 deuteriums on
benzo[a]pyrene-dn moiety. The mass spectrum ofBaP-C 8 Gua-dn by ESI is shown
in Figure 15.
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Figure 15. Mass Spectrum o f BaP-C8 Gua-dn by ESI.
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The daughter (MS/MS) mass spectrum o f BaP-C8 Gua-dn by ESI was
obtained by selectively passing m/z 413 ion through the first quadrupole,
bombarding the ion by inducing argon gas in the second quadrupole and then
analyzing with the third quadrupole. Upon collision (collision energy set at 35V to
monitor the parent compound), the 413 ion decomposes to produce the most
abundant ion o f m/z 287 and it is likely to be BaP-CN^-dio. The formation o f BaPCN^-dio (m/z 287) instead o f BaP-CN^-dn (m/z 288) indicates a possible
deuterium/hydrogen exchange during the fragmentation. The daughter (MS/MS)
mass spectrum ofBaP-C 8 Gua-dn by ESI is shown in Figure 16.
Similar to the BaP-C8 Gua spectrum, the greater abundance o f the m/z 287
observed in the spectrum ofBaP-C 8 Gua-dn as compared withBaP-N7Gua-dn is
H -

•+

attributed to the greater stability o f BaP-CN -dio versus BP-NC -dio- This unique
difference provides a rapid distinguishing characteristic between BaP-C8 Gua-dj i
and BaP-N7Gua- dn. In addition to the above, the fragment ion of m/z 396 is
assigned as (M+H-NH3)+ and m/z 371 is assigned as (M+H- NH2 CN)*
The BaP-N7Gua-dn>mass spectrums obtained by electrospray showed
excellent correlation with the spectrum o f BaP-N7Gua. The (M+H)+ ion o f m/z 413
is eleven units higher than BaP-N7Gua which refers to the eleven deuteriums on the
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Figure 16. Daughter Mass Spectrum (MS/MS) ofBaP-C 8 Gua-dn by ESI. Collision
energy set at 35 V.

benzo[a]pyrene-dn moeity. The mass spectrum ofBaP-N7Gua-dn by ESI is shown
in Figure 17.
The daughter (MS/MS) mass spectrum ofBaP-N7Gua-dn by ESI was
obtained by select passing m/z 413 ion through first quadrupole, bombarding the ion
by inducing argon gas in the second quadrupole and then analyzing with the third
quadrupole. Upon collision (collision energy 35V), the 413 ion decomposes to
produce the most abundant ions o f m/z 263 and 287. The m/z o f 263 is the 11
deuterated benzo[a]pyrene moiety and m/z 287 ion is the BaP-CN -dio. The
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Figure 17. Mass Spectrum ofBaP-N7Gua-dn by ESI.

formation o f BaP-CN^-dio (m/z 287) instead o f d11-BaP-CN + (m/z 288) indicates a
possible deuterium/hydrogen exchange during the fragmentation. The daughter
(MS/MS) mass spectrum ofBaP-N7Gua-dn by ESI is shown in Figure 18.
The m/z 263 ion is the benzo[a]pyrene-dn moiety resulting from facile
protonation at N7 position o f BaP-N7Gua-di i followed by a loss o f the neutral
guanine moiety. The greater abundance o f the m/z 263 in the daughter mass
spectrum o f BaP-N7Gua-dnas compared with BaP-C8 Gua-dn is very unique. This
unique difference provides a rapid distinguishing characteristic between
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Figure 18. Daughter Mass Spectrum (MS/MS) ofBaP-N7Gua-dn by ESI. Collision
energy set at 35 V.

BaP-C8 Gua-di i and BaP-N7Gua- di i. In addition to above, the fragment ion o f m/z
396 is assigned as (M+H-NH 3 )+ and m/z 371 is assigned as (M+H- NH2 CN)+.

MS/MS/MRM Optimization
In order to achieve the maximum sensitivity for our analysis, the
electrospray current voltage and collision energy effects for both adducts were
carefully studied and revised to obtain the best operating conditions.
The electrospray current for BaP-C 8 Gua and BaP-N7Gua which gave the
most intense signal at MH+ (m/z 402) was 3 kV. The intensity o f m/z 402 ion signal
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for both adducts decreased when lower ionization energy was applied. The
decreased sensitivity may have been caused by incomplete sample ionization.
The intensity o f m/z 402 ion signal for both adducts also decreased when a
higher ionization energy was applied. The decreased sensitivity may have been
caused by an arcing effect or sample break down. In addition to the above
phenomenon, high background noise was observed when higher ionization energy
was used. The results o f the electrospray current study are shown in Figure 19.

350000 n
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300000 ■a—
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Figure 19. The Electrospray Current Voltage (kV) vs. Response by Infusion
Method.
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The collision energy for BaP-C8 Gua and BaP-N7Gua which produced the
most intense signal for their respective daughter ions m/z 277 (most abundant
fragment) was 40 V. The intensity o f m/z 277 ion for both adducts decreased when
high collision energy was applied.
The decreased sensitivity may have been caused by excessive fragmentation
or further break down o f the daughter ion. The optimized conditions were used for
LC/MS/MS/MRM (m/z 402 — > m/z 277) sample analysis in order to obtain the
maximum sensitivity. The results o f the collision energy study are shown in Figure
20 .
LC/MS/MS/MRM Method
Two fragment ions were selected for the LC/MS/MS/MRM analysis for both
authentic and deuterated standards. For BaP-C8 Gua and BaP-N7Gua, m/z 402
277 (major) and m/z 402

360 (minor) transitions were monitored. For the internal

standards (BaP-C8 Gua-du and BaP-N7Gua-dn) m/z 413

287 (major) and m/z

413-> 371(minor) transitions were monitored. The standard curves were constructed
by three replicated analyses o f solutions containing BaP-C8 Gua and BaP-N7Gua,
from

1

to 32 ng ( 1 , 2, 4, 8 , 16, and 32 ng) per injection and internal standards (BaP-

C8 Gua-di i and BaP-N7Gua-di i ), containing 2 ng per injection in all o f the
solutions. Results from LC/MS/MS/MRM are very linear.
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Figure 20. The Collision Energy (V) vs. Response o f m/z 277 Ion by Infusion
Method.

The response ratio o f BaP-C8 Gua to BaP-C8 Gua-dn was linear and it is
presented as Figure 21.
The standard plot was constructed based on peak height instead o f peak area
2

to achieve a more accurate result. The linear equation o f y = 1.0967x and R =
0.9998 were obtained with accuracy from 93% to 111% (Tablel). The standard
deviation o f three injections for all levels o f standards was less than 5.6% and the
highest percent relative standard deviation (%RSD) for all levels of standard
injections was less than 5.5%. The limit o f detection (LOD) forBP-C 8 Gua
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Figure 21. The Standard Plot o f BaP-C 8 Gua by LC/MS/MS/MRM.
standards was 77 pg (192 /m ole (S/N = 3) and limit o f quantitation (LOQ) was 153
pg (381 /m ole)(S/N = 6 ).
The response ratio ofBaP-N7Gua to BaP-N7Gua-dn was linear and it is
presented as Figure 22.
The standard plot was constructed based on peak height instead o f peak area
2

to achieve a more accurate result. The linear equation o f y = 0.3945x and R =
0.9999 were obtained with accuracy from 96% to 111% (Table 2). The highest
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Table 1
BaP-C8Gua LC/MS/MS/MRM Linear Plot Accuracy Calculation
BaP-C8 Gua
on column
(ng)
1 .0 0
1 .0 0
1 .0 0
2 .0 0

BaP-C8 Gua
Calculated
(ng)
1.08

Accuracy
(%)

1.05
1.03
2.09

105
103
104

2 .2 2

111

2 .0 0

2 .0 2

101

4.00

4.22

106

8 .0 0

3.73
4.13
8.51

%RSD

105 ± 2 .1

2 .0 0

105 ± 4 .2

4.00

101 ± 5 .6

5.54

102 ± 3 .1

3.04

102 ± 2.5

2.45

99 ± 3 .4

3.43

108

2 .0 0

4.00
4.00

Average %
accuracy ±
standard deviation

93
103
106

8 .0 0

8 .0 0

100

8 .0 0

16.00

7.90
16.23

101

16.00
16.00
32.00

16.50
15.79
30.78

105
99
96

32.00
32.00

33.32
31.37

104
98

99

standard deviation o f three injections for all standard injections was less than 4.1%
and the %RSD for all levels o f standards was less than 3.9%. The limit o f detection
(LOD) for bap-N7Gua standards was 96 pg (239 /mole) (S/N = 3) and limit o f
quantitation (LOQ) was 192 pg (477 /m ole)(S/N =6 ).
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Figure 22. The Standard Plot o f BaP-N7Gua by LC/MS/MS/MRM.
These results indicate that the method is accurate and precise. Our
LC/MS/MS/MRM method demonstrated the ultimate advantage over traditional
UV-VIS or FLR detection methods by having extremely low LOD and LOQ values.
Both values are important for trace level analysis, especially, when analyzing bio
samples.
Chromatographic separation between BaP-C8 Gua and BaP-N7Gua peaks was
very good. The resolution between the two peaks was 6.36. The tailing factor for
BP-C 8 Gua was 1.07 and 1.24 for BaP-N7Gua at 5% peak height. Both the
resolution and tailing factor were calculated based on the 8 ng o f analytes on
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Table 2
BaP-N7Gua LC/MS/MS/MRM Linear Plot Accuracy Calculation
BaP-N7Gua
on column
(ng)
1 .0 0
1 .0 0

BaP-N7Gua
Calculated
(ng)
1.07

Accuracy
(%)

1 .0 1

1 .0 0

1 .1 1

111

2 .0 0

2.04
2.06
2.05
4.17
4.18
4.17
8.06
8.18
8.16
15.61
16.16
15.93
30.91
32.42
32.60

102

2 .0 0

4.00
4.00
4.00
8 .0 0
8 .0 0
8 .0 0

16.00
16.00
16.00
32.00
32.00
32.00

% RSD

106 ± 4 .1

3.87

102 ± 0.5

0.49

104 ± 0 .5

0.48

102 ± 0 .5

0.49

99 ± 1.2

1 .2

±

2 .6

107
101

2 .0 0

Average % accuracy
± standard deviation

103
102

104
105
104
101
102
102

98
101
100

96
101

100

2 .6

102

column standard injection. The above result showed an outstanding improvement
when compared with the literature methods (Cavalieri et al., 1990; Chen et al.,
1996; Devanesan et al., 1996; Rogan et al., 1988). Our method not only provides
better sensitivity, accuracy, and precision, but also provides confirmation
information. The time saving by using our LC/MS/MS/MRM method was very
significant. Our method was three times faster than the other methods and provided
much more information than that provided by UV detection. Representative
chromatograms of standard injections are illustrated in Figure 23.
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Figure 23. Representative LC/MS/MS/MRM Chromatograms o f the Blank and
Standard Injections. (From left to right, Blank injection, Std injection [1
ng on column per adduct]. Top channel is the transition for internal
standards [m/z 413~> 287 and 371] and the bottom channel is transition
for adducts [m/z 402-^277 and 360], The early eluter is the BaP-C 8 Gua
and the late eluter is BaP-N7Gua).
Adducts Stability Evaluation and Method Suitability
The efficiency o f the Sep-Pack cleaning procedure and stability o f both
adducts were very good. For this study, the efficiency o f the Sep-Pack clean up
procedure was tested by adding the internal standards into the post Sep-Pack
cartridge clean up fraction instead o f pre-cartridge. The adduct stability was tested
by treating sample at extreme conditions for an extended period.
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Samples prepared at extreme conditions (0.02N HC1 at 75 °C for 1.5 hours)
were observed to be very stable and the Sep-pack procedure showed high efficiency.
N o significant adduct loss was observed throughout the study.
The recovery for BaP-C8 Gua was from 95% to 105% and the average
recovery was 98%. Results and additional details are presented in Table 3.

Table 3
Stability Study o f BaP-C8 Gua
BaP-C8 Gua
ng on column
1 .0
1 .0

5.0
5.0

BaP-C8 Gua
Calculated (ng)
0.99
1.05
4.88
4.90

Recovery
(%)
99
105
98
98

1 0 .0

1 0 .0 1

100

1 0 .0

10.08
19.51
19.81
28.94
28.48

101

2 0 .0
2 0 .0

30.0
30.0

98
99
96
95

The recovery for BaP-N7Gua was from 97% to 107% and the average
recovery was 101%. Results and additional details are presented in Table 4.
The above data indicate that both adducts are very stable at elevated
temperature, and the acid hydrolysis procedure does not cause significant break
down o f the adducts. The approximate 100% recovery for both adducts indicates no
adduct loss during the Sep-Pack clean up. The internal standards added on the postSep-Pak column served as an indicator (fixed numerator). Therefore, any adduct lost
during the Sep-Pak clean up procedure would be detected by a decreasing ratio. The
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Table 4
Stability Study o f BaP-N7Gua
BaP-N7Gua
on column (ng)
1.0
1.0
5.0
5.0
10.0
10.0
20.0
20.0
30.0
30.0

BaP-N7Gua
Calculated (ng)
1.04
0.98
5.33
5.21
9.57
10.00
19.11
20.51
31.66
30.53

Recovery
(%)
104
98
107
104
96
100
96
103
106
102

excellent recovery demonstrated a high efficiency for the Sep-Pak clean up
procedure. Representative chromatograms o f stability samples are shown in Figure

The recovery o f authentic adducts spiked in rat liver D N A was good and the
blank rat liver DNA preparation showed no interference peak when compared with
the spike. For BaP-C8Gua, the recovery range was from 82% to 101% and the
average recovery was 93%. For BaP-N7Gua, the recovery range was from 83% to
104% and the average recovery was 94%.
For the BaP-C8Gua, the limit of detection (LOD) o f rat liver DNA spike was
98 pg (61 /mole/mg DNA) (S/N = 3) and limit o f quantitation (LOQ) was 196 pg
(122 /m ole/m g DNA) (S/N = 6). For the BaP-N7Gua, the LOD was 99 pg (62
/m ole/m g DNA) and LOQ was 198 pg (124 /m ole/m g DNA). The LOD and LOQ
for both adducts in rat liver DNA spikes were very close to the values that were
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Figure 24. Representative LC/MS/MS/MRM Chromatograms o f the Blank and
Recovery/Stability Samples. (From left to right, blank injection, recovery
sample [1 ng on column per adduct]. Top channel is the transition for
internal standards [m/z 413-> 287 and 371] and the bottom channel is
the transition for adducts [m/z 402-^277 and 360], The early eluter is
BaP-C8Gua and the late eluter is BaP-N7Gua).
calculated from their pure form injections (see standard plots). The above data
indicate that the method is valid, rugged, free o f bias, and well suited for DNA
analysis. Results and additional details are presented in Tables 5 and 6.
Representative chromatograms o f DNA spike are presented in Figure 25.
The recovery o f authentic adducts spiked into rat urine was good and the
blank rat urine extraction showed no interference peak when compared with the
spike. For BaP-C8Gua, the recovery range was from 91% to 104% and the average
recovery was 95%. Results and additional details are presented in Table 7.
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Table 5
Recovery Study o f BaP-C8Gua Spiked on Rat Liver DNA
BaP-C8Gua
on column (ng)
1.0
1.0
5.0
5.0
10.0
10.0
20.0
20.0
30.0
30.0

BaP-C8Gua
Calculated (ng)
0.82
0.99
4.43
4.62
9.21
9.23
20.14
17.36
28.99
29.41

Recovery
(%)
82
99
89
92
92
92
101
87
97
98

Table 6
Recovery Study o f BaP-N7Gua Spiked on Rat Liver DNA
BaP-N7Gua
on column (ng)
1.0
1.0
5.0
5.0
10.0
10.0
20.0
20.0
30.0
30.0

BaP-N7Gua
Calculated (ng)
0.83
1.04
4.16
4.64
9.53
9.55
19.63
17.65
31.33
27.94

Recovery
(%)
83
104
83
93
95
96
98
88
104
93

For BaP-N7Gua, the recovery range was from 91% to 106% and the average
recovery was 99%. Results and additional details are presented in Table 8.
For the BaP-C8Gua, the limit o f detection (LOD) o f spike on rat urine bio
sample was 146 pg (73 /mole/mL urine) (S/N = 3) and limit o f quantitation (LOQ)
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Figure 25. Representative LC/MS/MS/MRM Chromatograms o f the Bio-Sample
Spike Studies. (From left to right, rat liver DNA blank, rat liver DNA
spike [ln g on column per adduct], rat urine blank, rat urine spike [ln g on
column per adduct], rat feces blank, rat feces spike [lng on column per
adduct]. Top channel is the transition for internal standards [m/z 413->
287 and 371] and the bottom channel is the transition for adducts [m/z
402->277 and 360], The early eluter is BaP-C8Gua and the late eluter is
BaP-N7Gua).

was 293 pg (146 /mole/mL urine) (S/N = 6). For the BaP-N7Gua, the LOD was 125
pg (62 /mole/mL urine) and LOQ was 250 pg (124 /mole/mL urine).
The LOD and LOQ results for both adducts in bio-sample (urine) spikes
were similar to the injections o f their pure forms (from standard plots) indicating
that the method is free from bias.
The above data indicate that the method is rugged and robust and is well
suited for different types o f bio-sample analysis. Representative chromatograms o f
rat urine spikes are presented in Figure 25.
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Table 7
Recovery Study o f BaP-C8Gua Spiked in Rat Urine
BaP-C8Gua
on column (ng)
1.0
1.0
5.0
5.0
10.0
10.0
20.0
20.0
30.0
30.0

BaP-C8Gua
Calculated (ng)
0.93
0.91
4.57
4.60
9.99
9.62
19.61
20.75
27.34
29.79

Recovery
(°/o)....................
93
91
91
100
96
91
98
104
91
99

Table 8
Recovery Study of BaP-N7Gua Spiked in Rat Urine
BaP-N7Gua
on column (ng)
1.0
1.0
5.0
5.0
10.0
10.0
20.0
20.0
30.0
30.0

BaP-N7Gua
Calculated (ng)
1.02
1.01
5.15
5.29
9.81
9.69
19.41
19.91
29.79
27.35

Recovery
(%)
102
101
103
106
98
97
97
100
99
91

The recovery o f authentic adducts spiked in rat feces was also good and the
blank rat feces extraction showed no interference peak when compared with the
spike. For BaP-C8Gua, the recovery range was from 82% to 94% and the average
recovery was 88%. Results and additional details are presented in Table 9. For
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Table 9
Recovery Study o f BaP-C8Gua Spiked in Rat Feces
BaP-C8Gua
on column (ng)
1.0
1.0
5.0
5.0
10.0
10.0
20.0
20.0
30.0
30.0

BaP-C8Gua
Calculated (ng)
0.87
0.88
4.67
4.36
8.36
8.16
17.42
17.78
27.89
28.19

Recovery
(%)
87
88
93
87
84
82
87
89
93
94

BaP-N7Gua, the recovery range was from 80% to 99% and the average recovery
was 87%. Results and additional details are presented in Table 10. For BaP-C8Gua,
the limit o f detection (LOD) o f spiked rat feces was 137 pg (340 /mole/gm feces)
(S/N = 3) and limit o f quantitation (LOQ) was 273 pg (679 /mole/gm feces) per
injection (S/N = 6). For the BaP-N7Gua, the LOD was 190 pg (472 /m ole/gm feces)
and the LOQ was 380 pg (946 /mole/gm feces). The slightly higher numbers
observed for LOD and LOQ o f spiked rat feces versus the results observed for
spiked DNA and urine samples were possibly due to the complexity o f the feces
sample matrix. Despite this, the LOD and LOQ for both adducts in bio-sample
(feces) spikes are still comparable to the LOD and LOQ o f their pure forms (from
standard curve data), thus proving the method is free from bias. The above data
indicate that the method is very rugged and robust and it is suitable for different
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types of bio-sample analysis. Representative chromatograms o f spiked rat feces are
presented in Figure 25.

Table 10
Recovery Study o f BaP-N7Gua Spiked in Rat Feces
BaP-N7Gua
on column (ng)
1.0
1.0
5.0
5.0
10.0
10.0
20.0
20.0
30.0
30.0

BaP-N7Gua
Calculated (ng)
0.81
0.87
4.32
4.43
8.00
8.24
16.98
16.46
29.80
28.92

Recovery
(°/o)
.............
81
87
86
89
80
82
85
82
99
96

The above study results have shown that our LC/MS/MS/MRM is valid. It
has excellent accuracy, precision, and has been shown to be very rugged and robust.
Our method has been proven far better than the traditional LC/UV or LC/FLR
methods (Cavalieri et al., 1990; Chen et al., 1996; Devanesan et al., 1996; Rogan et
al., 1988). Based on the above information, the advantages o f using our
LC/MS/MS/MRM method may be summarized as follows: (a) provides both
quantitative and qualitative information; (b) provides confirmation information (m/z
matching rather than UV absorbance); (c) efficient bio-sample analysis (because o f
the selectivity); (d) highly sensitive, selective, accurate, and precise; and (e) rugged,
robust, free o f bias, and time saving.
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In Vitro Experiment Results
The in vitro experiment results indicate that BaP-N7Gua is the major
depurinating adduct content for both calf thymus and rat liver D N A samples while
BaP-C8Gua were dominated in the stable adduct analysis. Blank preparation
showed no interference with our analysis and was bias free. The above result agrees
with the finding o f Rogan et al.(1988) and Devanesan et al. (1996). Once BaPN7Gua is formed it will break away from DNA faster than the BaP-C8Gua. The in
vitro results and additional details are presented in Table 11. LC/MS/MS/MRM
chromatograms are presented in Figure 26.

Table 11
In Vitro Sample Results
Sample ED

Calf
Thymus
DNA
Sample

Calf Thymus DNA
(Stable Adducts)
Calf Thymus DNA
(Depurinating Adducts)

Rat Liver
DNA
Sample

Rat liver DNA
(Stable Adducts)
Rat liver DNA
(Depurinating Adducts)

BaP-C8Gua
(ng)/% total
adduct
11.9 ng/26.1%

BaP-N7Gua
(ng)/% total
adduct
6.8 ng/14.9%

5.0 ng/11.0%

21.9 ng/48.0%

10.9 ng/35.7%

3.9 ng/12.8%

4.5 ng/14.8%

11.2 ng/36.7%
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Figure 26. Representative LC/MS/MS/MRM Chromatograms o f the Horseradish
Peroxidase Experiments. (From left to right, row 1-calf thymus DNA:
blank, stable adducts, depurinating adducts, row 2- rat liver DNA: blank,
stable adducts, depurinating adducts. Top channel is the transition for
internal standards [m/z 413-> 287 and 371] and the bottom channel is
the transition for adducts [m/z 402-^277 and 360]. The early eluter is
BaP-C8Gua and the late eluter is BaP-N7Gua).
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In Vivo Rat Experiment Results
The benzo[a]pyrene calibration plot generated for evaluating content
uniformity and potency o f the feed is presented in Figure 27.

B enzo[a]pyrene

soco

3000

!
2000

0

at

a 15

02

025

C&ncmgftnL

Figure 27. Benzo[a]pyrene Calibration Plot.

The uniformity and potency of the processed feed were evaluated before
dosing to ensure uniform exposure. The standard plot was constructed based on
peak area to achieve the more accurate result. The linear equation o f y = 23953x and
2

R = 0.9996 were obtained with accuracy from 99% to 104%. The standard
deviation o f three injections for all levels o f standards was less than 0.5% and the
highest percent relative standard deviation (%RSD) for all levels o f standard
injections was less than 0.5%. The above data indicates that the method is accurate
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and precise and is suitable for the analysis. Representative chromatograms o f feed
samples are shown in Figure 28.
OAQ1 A, a a=300.4R af=4S0.80 (BAPMD9-12-06.D)

mAU
800:

600
400

Benzo[a]pyrene

200

OAD1 A. S g= 300,« R «f=450.80 (BAFVJ1-18004.D)

mAU
800
600

Control

400

200

DAD1 A. S a =300,4 Ref=450,80 (BAPM208C002.D)

Medium dose

Figure 28. LC Chromatograms of Feed Samples.
For the in vivo rat study, the average weight gain o f the high dose group was
significant lower than other groups through out the study. The high dose rat
appeared to be sick after 4 weeks of dosing. Abnormal fur loss was observed. They
were less active than other groups and when surgery was performed we found that
their internal organs were morphologically different from other groups as well. The
in vivo rat experiment average weight gain results and corresponding dosages are
presented in Table 12. The average weight gain results verses feed consumption are
presented in Figures 29 and 30.
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Table 12
In Vivo Dosage and Average Weight Gain Result
Dosing
period
(Weeks)
High Dose
rat average
weight gain
(gm)
Medium
Dose rat
average
weight gain
(gm)
Low Dose
rat average
weight gain
(gm)

Control rat
average
weight gain

1

2

3

4

5

6

7

8

Average
weight
gain in gm

9.9

12.7

2.8

1.8

3.6

3.0

8.3

11.0

6.7 ± 4.0

23.1

20.4

12.5

11.8

9.0

9.3

7.0

9.7

12.9 ± 5.4

24.9

21.8

9.0

12.8

6.3

9.3

6.0

11.7

12.7 ± 6.5

20.9

20.1

9.3

10.2

8.7

7.3

7.7

10.0

11.8± 5.1

......(sm)
The in vivo rat experiment results and corresponding dosages are presented
in Table 13. No adduct was detected in rat livers at all dosage levels after dosing for
two weeks. Small amount o f BaP-C8Gua was found in all three high-dose rat livers
after four weeks o f dosing. Slightly more BaP-C8Gua was found in all three highdose rat livers after 8 weeks o f dosing.
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Table 13
In Vivo Dosage and Rat Liver Sample Result
Group
Number

1

Dosage
mg/Kg
per day

59.4

Number o f
rats
Euthanatized /
Analyzed
3
3
3

Dosing
period
(Weeks)

BaP-N7Gua
p mole/g
liver

2
4
8

BaPC8Gua
p mole/gm
liver
Non detected
8.6 ± 1.84
8.8 ± 2.49

Non detected
Non detected
Non detected

2
4
8

Non detected
Non detected
Non detected

Non detected
Non detected
Non detected

2

6.4

3
3
3

3

0.8

3
3
3

2
4
8

Non detected
Non detected
Non detected

Non detected
Non detected
Non detected

0.0

3
3
3

2
4
8

Non detected
Non detected
Non detected

Non detected
Non detected
Non detected

4

The above result agrees with the finding o f in vivo studies done by Rogan et
al. (1990), Ross et al. (1991) and Devanesan et al. (1996). Once BaP-N7Gua is
formed, it will break away from DNA faster than the BaP-C8Gua; therefore, no
BaP-N7Gua was expected to be found as stable adduct in the in vivo sample.
However, based on our in vitro study results and the in vivo experiment done by
Rogan et al. (1990) and Devanesan et al. (1996) the BaP-N7Gua is expected to be
the dominant depurinated adduct. We believed that most BaP-N7Gua exists as the
free adduct form and the total amount should be greater than BaP-C8Gua. Our
finding indicates that benzo[a]pyrene is bio-available through the oral route;
however, the finding o f adduct levels were very low. This may be caused by fast

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

depurination o f the adducts, low bioavailability, or different metabolic routes o f the
benzo[a]pyrene through oral exposure. Therefore, a large and chronic dose was
needed in order to see the detectable adduct formation in the liver sample.
Representative chromatograms o f in vivo rat samples are shown in Figure 31.

c o n tro l ra t* 9 !iv a r 1 -3 0 -0 1

S o

100*1

( M n . o o n M ia a e * « r S m ( M n .f c S )
Tl 100,

8 .0 0 #

Tl high doc* rat M h # r 1 -3001 S n (1*1.4*5J
8- 00*
8.00

A m , H a ig ft

Hwg

10.18

0
100-1

oj .............

c o n tr o l r» t# 9 liv # r 1 -3 0 -0 1 S o

i

9.62

...

( M n , e o n o d r a « 2 h m S m (M n .4*5)
T l 100-1

high do## i d 8 6 ivar 1-3001 Sm(A*i.4>t5}

8.0 0 a
A r a a , H e ig h

%

-

7.08
110
227
5 .0 0

10 .0 0

5 .00

-^-i Tim
15.00

SlOO

— lT u n
15.00

Figure 31. Representative LC/MS/MS/MRM Chromatograms of the In Vivo Rat
Experiment. (From left to right, control rat liver without internal
standards, with internal standards, high dose rat liver with internal
standards. Top channel is the transition for internal standards [m/z 413
287 and 371]and the bottom channel is the transition for adducts [m/z
402->277 and 360]. The early eluter is BaP-C8Gua and the late eluter is
BaP-N7Gua.)
In Vivo Fish Experiment Results
For the in vivo fish experiment, the uniformity and potency o f the processed
feed were evaluated before dosing to ensure uniform exposure. The HPLC method
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and calibration plot used to evaluate the benzo[a]pyrene potency o f fish feed was
the same as used for rat feed. No interference was found in any sample; therefore,
the determination o f the benzo[a]pyrene potency in fish feed was very straight
forward.
The above data indicate that our HPLC method was very rugged and bias
free and our quick HPLC method is suitable for similar analysis. Representative
chromatograms o f feed samples are shown in Figure 32.
DA01 A, Sig=*300,4 Raf=450,80 (BAPU39-12-02.D)

B en zo[a]pyrene S tandard
50

-50
DAD1 A. Sig=300,4 Ref=450.80 (BAP\020700G7.D)

so

m

C ontrol F ish F e e d

-so
DAD1 A. Sig=300,4 Ref=450.80 (BAP\02050002.D)

m

High D o se F ish F eed

mJ
Figure 32. LC Chromatograms o f Fish Feed Samples.

The in vivo fish experiment results and corresponding dosages are presented
in Table 14. No adduct was detected in fish livers at all dosage levels after dosing
for four weeks. We believe that the negative finding may be due to the fast
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depurination o f the adducts, low bioavailability, or different metabolic routes o f the
benzo[a]pyrene through the oral exposure. We also believe that the negative finding
was dose related. Even though the dose levels o f the benzo[a]pyrene in both
experiments were the same, because the feed consumption o f fish was much lower
than the feed consumption o f rat the total dosage on fish was much lower.
Table 14
In Vivo Dosage and Fish Liver Sample Result

4

BaPC8Gua
p mole/g
liver
Non detected

Non detected

13

4

Non detected

Non detected

0.1

13

4

Non detected

Non detected

0.0

14

4

Non detected

Non detected

Dosage
mg/Kg
per day

Number o f Fish
Euthanatized /
Analyzed

Dosing
period
(Weeks)

1

8.7

13

2

0.7

3

4

Group
Number

BaP-N7Gua
p mole/g
liver

In order to demonstrate that our method is bias free for fish liver samples,
two spike samples were prepared by addition o f both BaP-C8Gua and BaP-N7Gua
at 100 pg (on column) on control fish liver DNA and carried though the sample
preparation and then analyzed by our method. Both spikes show positive results
which indicate that our method is suitable for fish liver analysis. Representative
LC/MS/MS/MRM chromatograms o f in vivo fish samples are shown in Figure 33.
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According to our rat experiment results, we believe that a larger dose may needed in
order to see the detectable adduct formation in the fish liver sample.
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Figure 33. Representative LC/MS/MS MRM Chromatograms o f the In Vivo Fish
Experiment. (From left to right, control fish liver without internal
standards, with internal standards, with 100 pg [on column] standards
spike. Top channel is the transition for internal standards [m/z 413-> 287
and 371] and the bottom channel is the transition for adducts [m/z
402-^277 and 360]. The early eluter is BaP-C8Gua and the late eluter is
BaP-N7Gua.)
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CHAPTER V
CONCLUSION
High performance liquid chromatography coupled with tandem mass
spectrometer has proven to be very powerful instrumentation in the analysis o f DNA
adducts in complex biological tissues. Our study was focus on quantitative study o f
benzo[a]pyrene D N A nucleoside adducts in in vitro and in vivo samples by utilizing
this technique. The specific isotope internal standard method was used for our study
in order to achieve the best result.
Both standards (BaP-C8Gua and BaP-N7Gua) and internal standards (BaPC8Gua-dn and BaP-N7Gua-dn) were successfully synthesized. Avery rugged
LC/MS/MS/MRM method was developed by carefully studied the ionization
parameters. Our LC/MS/MS/MRM method is developed by setting the first
quadrupole o f the instrument to pass the MH+ at m/z 402 for both adducts and m/z
413 for both deuterated internal standards. The collision induced fragmentation that
occurred at the second quadrupole. The product ions (daughters) were separated in
the third quadrupole and two o f them were monitored. Our method has proven to be
very suitable for the analysis, it provides low detection limit, quick turnaround time,
additional specificity, and structure confirmation.
Our LC/MS/MS/MRM method has shown excellent accuracy, precision, and
has been proven to be very rugged and robust. Our method has been proven far
better than the traditional LC/UV or LC/FLR methods, especially for bio-sample
88
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analysis such as DNA, urine, and feces. The in vitro samples were obtained from the
horseradish peroxidase catalyst from both calf thymus and rat liver DNA with
benzo[a]pyrene. The in vivo samples were prepared by chronic dietary dosing Fisher
344 rats and bluegill fish with feed containing benzo[a]pyrene. Both in vitro and in
vivo samples were analyzed by our method and proven to be successful.
Based on the results o f our experiment, the advantages o f utilizing our
LC/MS/MS/MRM method for sample analysis may be summarized as follows:
(a) provides both quantitative and qualitative information; (b) provides confirmation
information (m/z matching rather than UV absorbance); (c) efficient bio-sample
analysis, despite the complexity o f sample matrix; (d) highly sensitive, selective,
accurate, precise, and reproducible; and (e) rugged, robust, free o f bias, and time
saving.
W e conclude that our method was suitable for bio-sample analysis and is
superior to traditional methods. Therefore, more research and application effort
should be made in liquid chromatography/tandem mass spectrometry and the
importance o f liquid chromatography/tandem mass spectrometry in future research
cannot be overemphasized.
The low findings o f the stable adducts in our in vivo experiment may be due
to a higher than expected excretion rate, low bioavailability, or different metabolic
routes o f the benzo[a]pyrene through oral exposure and thus, further study should be
considered.
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For future studies, a better formulation or dosing route should be used for
animal dosing in order to achieve better bioavailability. We should also look into the
formation o f adducts by both one-electron oxidation and monooxygenation routes.
For checking the excretion, animal feces, urine, and all the organs should be
collected and analyzed after dosing. A mass balance study should be performed in
order to better understand the distribution and excretion rate o f the adducts.
Furthermore, different PAHs should be included in the study to assess the
risk o f their carcinogenesis effects. B y gathering the information o f all these studies,
more information about cancer formation could be provided and lead to better cures
o f the disease.
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